{"text_format":"1","workbook":"xlsx","n_sheets":72,"sheets":["Summary","Infos","1) Exchange rates","2) Earnings summary","3) From AE to NI","4) MA - Group    ","5) MA - France   ","6) MA - Europe","7) MA -  Switzerland","8) MA - Germany","9) MA - Belgium","10) MA - UK.Ireland","11) MA - Spain","12) MA - Italy","13) MA - Asia","14) MA - Japan","15) MA - Hong Kong","16) MA - Asia High Potential_x000a_  ","17) MA - Asia Direct   ","18) MA - US ","19) AM - AUM Breakdown AB ","20) MA - AB","21) MA - International   ","22) MA - Transversal  ","23) AM - AUM Breakdown IM","24) MA - IM ","25) Inv Ass & NII - GRP(N-1)","26) Inv Ass & NII - GRP(N)","27) Inv Ass & NII - EUR(N-1)","28) Inv Ass & NII - EUR(N)","29) Inv Ass & NII ASIA(N-1)","30) Inv Ass & NII ASIA(N)","31) Inv Ass & NII -TRANS(N-1)","32) Inv Ass & NII -TRANS(N)","33) CoR - GROUP (N-1)","34) CoR - GROUP (N) ","35) CoR - EUROPE (N-1)","36) CoR -  EUROPE (N)","37) CoR -  ASIA (N-1) ","38) CoR -  ASIA (N)","39) CoR - TRANSVERSAL (N-1) ","40) CoR - TRANSVERSAL (N) ","41) Number of shares","42) Earnings per share","43) BS – assets","44) BS – liabilities","45) Shareholders equity","46) ROE","47) Financial structure","48) Int Ass - Group_x000a_    ","49) Int Ass - Europe  ","50) Int Ass - Asia    ","51) Int Ass - Transversal_x000a_    ","52) DAC – L&S N-1","53) DAC – L&S N","54) VBI  – L&S N-1","55) VBI  – L&S N","56) URGL","57) Assets under Management","58) Reserves L&S   ","59) P&C reserves N-1","60) P&C reserves N","61) P&C reserves ratios","62) IRR_Payback","63) APE - NBV Discrete N-1","64) APE - NBV Discrete N","65) NB APE, NBV, NBV MARGIN","66) GR L&S","67) GR Health","68) All Free cash flows","69) LnS Free cash flows","70) PnC & B&AM Free cash flows"],"not_rendered":{"charts":0,"images":0,"macros":1,"external_links":0,"defined_names":0,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Summary","index":0,"n_rows":72,"n_cols":1,"rows_kept":72,"cut":false,"hidden":false,"merged":[]}
["Summary"]
["Infos"]
["1) Exchange rates"]
["2) Earnings summary"]
["3) From AE to NI"]
["4) MA - Group    "]
["5) MA - France   "]
["6) MA - Europe"]
["7) MA -  Switzerland"]
["8) MA - Germany"]
["9) MA - Belgium"]
["10) MA - UK.Ireland"]
["11) MA - Spain"]
["12) MA - Italy"]
["13) MA - Asia"]
["14) MA - Japan"]
["15) MA - Hong Kong"]
["16) MA - Asia High Potential\n  "]
["17) MA - Asia Direct   "]
["18) MA - US "]
["19) AM - AUM Breakdown AB "]
["20) MA - AB"]
["21) MA - International   "]
["22) MA - Transversal  "]
["23) AM - AUM Breakdown IM"]
["24) MA - IM "]
["25) Inv Ass & NII - GRP(N-1)"]
["26) Inv Ass & NII - GRP(N)"]
["27) Inv Ass & NII - EUR(N-1)"]
["28) Inv Ass & NII - EUR(N)"]
["29) Inv Ass & NII ASIA(N-1)"]
["30) Inv Ass & NII ASIA(N)"]
["31) Inv Ass & NII -TRANS(N-1)"]
["32) Inv Ass & NII -TRANS(N)"]
["33) CoR - GROUP (N-1)"]
["34) CoR - GROUP (N) "]
["35) CoR - EUROPE (N-1)"]
["36) CoR -  EUROPE (N)"]
["37) CoR -  ASIA (N-1) "]
["38) CoR -  ASIA (N)"]
["39) CoR - TRANSVERSAL (N-1) "]
["40) CoR - TRANSVERSAL (N) "]
["41) Number of shares"]
["42) Earnings per share"]
["43) BS – assets"]
["44) BS – liabilities"]
["45) Shareholders equity"]
["46) ROE"]
["47) Financial structure"]
["48) Int Ass - Group\n    "]
["49) Int Ass - Europe  "]
["50) Int Ass - Asia    "]
["51) Int Ass - Transversal\n    "]
["52) DAC – L&S N-1"]
["53) DAC – L&S N"]
["54) VBI  – L&S N-1"]
["55) VBI  – L&S N"]
["56) URGL"]
["57) Assets under Management"]
["58) Reserves L&S   "]
["59) P&C reserves N-1"]
["60) P&C reserves N"]
["61) P&C reserves ratios"]
["62) IRR_Payback"]
["63) APE - NBV Discrete N-1"]
["64) APE - NBV Discrete N"]
["65) NB APE, NBV, NBV MARGIN"]
["66) GR L&S"]
["67) GR Health"]
["68) All Free cash flows"]
["69) LnS Free cash flows"]
["70) PnC & B&AM Free cash flows"]

{"sheet":"Infos","index":1,"n_rows":6,"n_cols":1,"rows_kept":6,"cut":false,"hidden":false,"merged":[]}
["Back to Summary"]
["http://iris/supfi/Financial Supp FY2017/Financial Supplement FY2017 - V3.docx"]
["Date :"]
["Wednesday, February 21, 2018"]
["Time :"]
["19:59:19"]

{"sheet":"1) Exchange rates","index":2,"n_rows":13,"n_cols":7,"rows_kept":13,"cut":false,"hidden":false,"merged":[[1,2,1,3],[1,5,1,6]]}
["Back to Summary"]
[null,null,"End of Period Exchange rate",null,null,"Average Exchange rate"]
[]
[null,null,"2017-12-31","2016-12-31",null,"2017-12-31","2016-12-31"]
[]
["USD",null,1.2010000000000001,1.0549999999999999,null,1.1299999999999999,1.105]
["JPY",null,135.27000000000001,123.021,null,126.711,121.22799999999999]
["GBP",null,0.88800000000000001,0.85399999999999998,null,0.877,0.81899999999999995]
["CHF",null,1.17,1.0720000000000001,null,1.1120000000000001,1.089]
["HKD",null,9.3870000000000005,8.1780000000000008,null,8.8049999999999997,8.5890000000000004]
["TRY",null,4.5529999999999999,3.71,null,4.1210000000000004,3.33]
["MXN",null,23.494,21.728999999999999,null,21.329000000000001,20.506]
["RUB",null,68.043999999999997,70.822999999999993,null,65.433000000000007,75.656999999999996]

{"sheet":"2) Earnings summary","index":3,"n_rows":28,"n_cols":22,"rows_kept":28,"cut":false,"hidden":false,"merged":[[27,0,27,21],[1,2,1,21],[3,0,4,0],[3,2,3,3],[3,4,3,5],[3,6,3,7],[3,8,3,9],[3,10,3,11],[3,12,3,15],[3,16,3,17],[3,18,3,21]]}
["Back to Summary"]
[null,null,"EARNINGS SUMMARY"]
[]
["CONSOLIDATED EARNINGS (in Euro million) - Group share",null,"Net income",null,"Exceptional and discontinued operations",null,"Integration and restructuring costs",null,"Goodwill and related Intangibles",null,"Profit or loss (including change) on financial assets (under Fair Value option) & derivatives",null,"Adjusted earnings",null,null,null,"Net realized capital gains attributable to shareholders",null,"Underlying earnings "]
[null,null,"FY 2016 restated","FY 2017","FY 2016 restated","FY 2017","FY 2016 restated","FY 2017","FY 2016 restated","FY 2017","FY 2016 restated","FY 2017","FY 2016 restated","FY 2017","Change reported","Change at constant FX","FY 2016 restated","FY 2017","FY 2016 restated","FY 2017","Change reported","Change at constant FX"]
[]
["Total",null,5829,6209,387,124,-454,-148,-89,-90,-118,-134,6103,6457,0.06,0.08,415,455,5688,6002,0.06,7.0000000000000007E-2]
["France",null,1509,1420,5,-252,-60,-25,0,0,27,31,1536,1666,0.08,0.09,152,237,1385,1429,0.03,0.03]
["Europe",null,1708,2435,-507,-57,-310,-25,-47,-44,30,-2,2543,2563,0.01,0.02,237,237,2305,2326,0.01,0.02]
["Switzerland",null,735,792,0,0,-2,0,-31,-28,-42,-43,810,864,7.0000000000000007E-2,0.09,49,55,761,809,0.06,0.08]
["Germany",null,525,621,-3,-87,-95,2,-4,-4,18,46,610,665,0.09,0.09,61,109,549,556,0.01,0.01]
["Belgium",null,349,475,0,34,-149,23,-2,-4,34,16,466,406,-0.13,-0.13,107,49,359,357,-0.01,-0.01]
["United Kingdom & Ireland",null,-184,243,-505,7,-26,-22,-5,-4,21,-32,331,295,-0.11,-0.06,11,13,320,282,-0.12,-7.0000000000000007E-2]
["Spain",null,125,140,-1,-2,-28,-16,-5,-4,13,-2,146,163,0.12,0.12,5,4,140,159,0.13,0.13]
["Italy",null,159,164,3,-9,-10,-10,0,0,-15,13,180,170,-0.06,-0.06,4,6,176,164,-7.0000000000000007E-2,-7.0000000000000007E-2]
["Asia",null,1096,1028,0,0,0,-9,-15,-16,45,-59,1066,1111,0.04,0.08,19,23,1047,1089,0.04,7.0000000000000007E-2]
["Japan",null,568,497,0,0,0,-2,0,0,69,-8,499,506,0.01,0.06,19,9,480,497,0.04,0.08]
["Hong Kong",null,375,373,0,0,0,-5,-14,-15,6,1,384,393,0.03,0.05,-5,2,389,392,0.01,0.03]
["Asia High Potentials",null,139,129,0,0,0,-2,0,0,-29,-54,168,185,0.1,0.12,8,14,161,171,0.06,0.08]
["Asia - Direct ",null,23,35,0,0,0,0,0,0,0,0,24,35,0.45,0.5,-3,-2,27,37,0.37,0.41]
["United States",null,1944,1415,973,268,-18,-21,0,-2,-17,96,1006,1075,7.0000000000000007E-2,0.09,8,-60,998,1135,0.14000000000000001,0.16]
["International",null,243,276,6,-22,-29,-16,-24,-27,22,11,267,330,0.23,0.26,-21,-7,288,337,0.17,0.2]
["Transversal & central holdings",null,-671,-365,-91,187,-37,-53,-3,-1,-225,-211,-315,-288,0.09,0.1,20,26,-335,-313,0.06,0.08]
["AXA Investment Managers",null,265,322,36,68,-4,-12,0,-1,8,10,225,257,0.14000000000000001,0.16,0,0,225,257,0.14000000000000001,0.16]
["AXA Corporate Solutions Assurance",null,149,40,6,-6,-8,0,0,0,4,-36,146,81,-0.45,-0.45,25,31,122,50,-0.59,-0.59]
["AXA Assistance",null,-5,14,0,-1,-17,-5,0,0,-2,-7,14,28,1.04,1.04,0,0,13,27,1.04,1.04]
["Other (a)",null,-1080,-741,-134,125,-8,-36,-3,0,-236,-178,-700,-653,7.0000000000000007E-2,7.0000000000000007E-2,-5,-6,-695,-648,7.0000000000000007E-2,7.0000000000000007E-2]
["(a) Other includes AXA Art, AXA Liabilities Managers, AXA Global Re, AXA Life Europe, AXA SA and other Central Holdings."]

{"sheet":"3) From AE to NI","index":4,"n_rows":31,"n_cols":11,"rows_kept":31,"cut":false,"hidden":false,"merged":[[1,0,1,10],[2,6,2,10],[3,0,3,1],[3,6,3,10],[5,0,5,4],[5,6,5,10],[13,7,13,8],[6,0,6,1],[6,6,6,7],[7,0,7,2],[7,6,7,8],[9,1,9,2],[9,7,9,8],[10,1,10,2],[10,7,10,8],[11,1,11,2],[11,7,11,8],[12,7,12,8],[22,1,22,2],[22,7,22,8],[14,1,14,2],[14,7,14,8],[15,7,15,8],[16,7,16,8],[17,0,17,1],[17,6,17,8],[19,1,19,2],[19,7,19,8],[20,1,20,2],[20,7,20,8],[21,7,21,8],[30,9,31,9],[30,10,31,10],[32,0,32,10],[23,7,23,8],[25,7,25,8],[26,7,26,8],[27,7,27,8],[30,1,31,1],[30,3,31,3],[30,4,31,4],[30,7,31,7]]}
["Back to Summary"]
["FROM ADJUSTED EARNINGS TO NET INCOME / IMPACT FROM CERTAIN OPERATIONS "]
[null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million) ",null,null,null,null,null,"Financial Statements "]
[]
["From Adjusted Earnings to Net Income",null,null,null,null,null,"Exceptional and discontinued operations"]
["Nature",null,null,"FY 2016 (Restated)","FY 2017",null,"Nature",null,null,"FY 2016 (Restated)","FY 2017"]
["Profit or loss (including change) on financial assets (under fair value option) & derivatives ",null,null,-118,-134,null,"M&A transactions",null,null,505,-88]
[]
[null,"* Of which change in fair value of assets accounted for as fair value option",null,40,222,null,null,"* Of which the exceptional result associated with the disposal of two real estate properties in the United States",null,972]
[null,"* Of which gains (losses) on interest rate economic hedges not eligible for hedge accounting under IAS 39",null,-197,-205,null,null,"* Of which the realized loss following the disposal of the United Kingdom Life & Savings operations",null,-439]
[null,"* Of which gains (losses) on Forex economic hedges not eligible for hedge accounting under IAS 39",null,40,-152,null,null,"* Of which the realized loss following the disposal of the P&C commercial broker in UK \"Bluefin Insurance Group\"",null,-82]
[null,null,null,null,null,null,null,"* Of which the exceptional result associated to the sale of the Hungarian banking operations",null,13]
[null,null,null,null,null,null,null,"* Of which the realized gain following the disposal of AXA Portugal",null,41,-1]
[null,null,null,null,null,null,null,"* Of which the negative impact related to the disposal of a part of the occupational pension business in Germany",null,null,-87]
[]
[]
["Other items",null,null,-156,-114,null,"Other operations",null,null,-118,212]
[]
[null,"* Of which goodwill and related intangibles",null,-89,-90,null,null,"* Of which restructuring of the participation in Bharti AXA Life Insurance Co. Ltd and Bharti AXA General Insurance",null,-61]
[null,"* Of which integration and restructuring costs",null,-454,-148,null,null,"*Of which partial write-off of the net deferred tax position effective in the coming year",null,-80,138]
[null,null,null,null,null,null,null,"due to the decrease in the French corporate tax rate from 34% to 26% enacted in 2017",null,-80,-191]
[null,"* Of which exceptional and discontinued operations ",null,387,124,null,null,"due to the decrease in the Belgian corporate tax rate from 34% to 25% enacted in 2017",null,null,41]
[null,null,null,null,null,null,null,"due to the decrease in the US corporate tax rate from 35% to 21% enacted in 2017",null,null,288]
[]
[null,null,null,null,null,null,null,"* Of which the adverse impact of regulatory changes on annuity legal indexation at AXA France",null,null,-206]
[null,null,null,null,null,null,null,"* Of which the refund of the 3% tax on dividends in France",null,null,249]
[null,null,null,null,null,null,null,"* Of which a positive adjustment to the deferred consideration linked to the disposal of AXA Private Equity in 2013",null,null,68]
[]
[]
[null,"Total",null,-274,-248,null,null,"Total",null,387,124]

{"sheet":"4) MA - Group    ","index":5,"n_rows":25,"n_cols":13,"rows_kept":25,"cut":false,"hidden":false,"merged":[[7,2,7,6],[7,8,7,12],[1,0,1,12],[2,0,2,12],[3,0,3,12],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,6,5,6],[4,7,5,7],[4,8,5,8],[4,9,5,9],[4,10,4,12],[5,10,5,12]]}
["Back to Summary"]
["MARGIN ANALYSIS"]
["GROUP"]
[]
["(Euro million) ",null,null,null,null,null,null,null,null,null,"AXA Consolidated"]
[null,null,null,null,null,null,null,null,null,null,"Financial statements"]
[]
[null,null,"Period ended December 31, 2016 (Restated)",null,null,null,null,null,"Period ended December 31, 2017"]
[null,null,"TOTAL","Life & Savings","Property & Casualty ","Health","Other",null,"Total","Life & Savings","Property & Casualty ","Health","Other"]
[]
["Investment margin  ",null,4867,2601,2148,117,null,null,4647,2476,2049,121]
["Fees & revenues ",null,8009,6534,null,1474,null,null,8123,6609,null,1514]
["Net technical margin ",null,12295,1294,9821,1181,null,null,11929,763,9882,1285]
["Expenses ",null,-17360,-6657,-8657,-2046,null,null,-16898,-6049,-8704,-2146]
["Amortization of value of business in force (gross of tax expenses)",null,-169,-163,null,-6,null,null,-42,-44,null,2]
[]
["Underlying earnings before tax from insurance activities",null,7641,3609,3312,720,null,null,7758,3755,3228,776]
[]
["Underlying earnings before tax from other activities",null,56,null,null,null,56,null,-2,null,null,null,-2]
[]
["Income tax expenses/benefits",null,-1908,-629,-878,-211,-190,null,-1665,-579,-884,-219,17]
["Income from affiliates and associates",null,239,174,48,3,13,null,297,175,96,2,24]
["Minority interests",null,-340,-77,-55,4,-213,null,-387,-62,-56,-7,-261]
[]
["Underlying earnings Group share",null,5688,3078,2427,516,-332,null,6002,3288,2384,552,-222]

{"sheet":"5) MA - France   ","index":6,"n_rows":25,"n_cols":13,"rows_kept":25,"cut":false,"hidden":false,"merged":[[26,0,26,8],[1,0,1,12],[2,0,2,12],[3,0,3,12],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,6,5,6],[4,7,5,7],[4,8,5,8],[4,9,5,9],[4,10,4,12],[5,10,5,12],[7,2,7,6],[7,8,7,12]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" FRANCE "]
[]
[" (Euro million)  ",null,null,null,null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other ",null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other "]
[]
[" Investment margin   ",null,1688,1094,541,54,null,null,1640,1073,517,51]
[" Fees & revenues  ",null,1771,1156,null,615,null,null,2001,1308,null,693]
[" Net technical margin  ",null,2800,469,2305,26,null,null,2909,501,2352,55]
[" Expenses  ",null,-4328,-1793,-1941,-594,null,null,-4531,-1874,-1961,-696]
[" Amortization of value of business in force (gross of tax expenses) ",null,"                     -   ","                     -   ",null,"                     -   ",null,null,"                     -   ","                     -   ",null,"                     -   "]
[]
[" Underlying earnings before tax from insurance activities ",null,1931,926,905,100,null,null,2018,1007,908,103]
[]
[" Underlying earnings before tax from other activities ",null,-2,null,null,null,-2,null,-7,null,null,null,-7]
[]
[" Income tax expenses/benefits ",null,-556,-224,-293,-33,-6,null,-598,-248,-312,-34,-4]
[" Income from affiliates and associates ",null,17,9,9,"                     -   ","                     -   ",null,20,8,12,"                     -   ","                     -   "]
[" Minority interests ",null,-5,-2,-1,"                     -   ",-2,null,-5,-2,-1,"                     -   ",-2]
[]
["Underlying earnings Group share",null,1385,708,620,67,-11,null,1429,765,608,69,-13]

{"sheet":"6) MA - Europe","index":7,"n_rows":25,"n_cols":13,"rows_kept":25,"cut":false,"hidden":false,"merged":[[7,2,7,6],[7,8,7,12],[1,0,1,12],[2,0,2,12],[3,0,3,12],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,6,5,6],[4,7,5,7],[4,8,5,8],[4,9,5,9],[4,10,4,12],[5,10,5,12]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" EUROPE "]
[]
[" (Euro million)  ",null,null,null,null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other ",null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other "]
[]
[" Investment margin   ",null,1968,885,1051,32,null,null,1813,810,976,27]
[" Fees & revenues  ",null,1224,1123,null,101,null,null,1158,1064,null,93]
[" Net technical margin  ",null,6155,349,5115,690,null,null,6200,374,5128,698]
[" Expenses  ",null,-6134,-1178,-4350,-606,null,null,-5965,-1094,-4277,-595]
[" Amortization of value of business in force (gross of tax expenses) ",null,-127,-126,null,-1,null,null,-25,-27,null,2]
[]
[" Underlying earnings before tax from insurance activities ",null,3085,1053,1817,216,null,null,3180,1127,1827,226]
[]
[" Underlying earnings before tax from other activities ",null,91,null,null,null,91,null,24,null,null,null,24]
[]
[" Income tax expenses/benefits ",null,-792,-236,-451,-62,-42,null,-807,-280,-453,-63,-12]
[" Income from affiliates and associates ",null,2,"                     -   ","                     -   ","                     -   ",2,null,7,"                     -   ","                     -   ","                     -   ",7]
[" Minority interests ",null,-82,-68,-14,"                     -   ",0,null,-78,-58,-19,"                     -   ",0]
[]
["Underlying earnings Group share",null,2305,749,1351,154,52,null,2326,789,1355,164,19]

{"sheet":"7) MA -  Switzerland","index":8,"n_rows":23,"n_cols":11,"rows_kept":23,"cut":false,"hidden":false,"merged":[[5,9,5,10],[7,2,7,5],[7,7,7,10],[1,0,1,10],[2,0,2,10],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,6,5,6],[4,7,5,7],[4,8,5,8],[4,9,4,10]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" SWITZERLAND "]
[]
[" (Euro million)  ",null,null,null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," Life & Savings "," Property & Casualty  "," Health ",null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "]
[]
[" Investment margin   ",null,385,212,173,"                     -   ",null,382,212,170,"                     -   "]
[" Fees & revenues  ",null,347,347,null,"                     -   ",null,333,333,null,"                     -   "]
[" Net technical margin  ",null,1393,203,1191,"                     -   ",null,1391,206,1184,0]
[" Expenses  ",null,-1096,-333,-762,"                     -   ",null,-1077,-318,-748,-11]
[" Amortization of value of business in force (gross of tax expenses) ",null,-77,-77,null,"                     -   ",null,-14,-14,null,"                     -   "]
[]
[" Underlying earnings before tax from insurance activities ",null,952,351,601,"            -   ",null,1014,419,606,-11]
[]
[" Income tax expenses/benefits ",null,-186,-63,-123,"                     -   ",null,-202,-86,-118,2]
[" Income from affiliates and associates ",null,"                     -   ","                     -   ","                     -   ","                     -   ",null,"                     -   ","                     -   ","                     -   ","                     -   "]
[" Minority interests ",null,-4,"                     -   ",-4,"                     -   ",null,-4,"                     -   ",-4,"                     -   "]
[]
["Underlying earnings Group share",null,761,287,474,"            -   ",null,809,333,484,-9]

{"sheet":"8) MA - Germany","index":9,"n_rows":25,"n_cols":13,"rows_kept":25,"cut":false,"hidden":false,"merged":[[26,0,26,5],[1,0,1,12],[2,0,2,12],[3,0,3,12],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,6,5,6],[4,7,5,7],[4,8,5,8],[4,9,5,9],[4,10,4,12],[5,10,5,12],[7,2,7,6],[7,8,7,12]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" GERMANY "]
[]
[" (Euro million)  ",null,null,null,null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other ",null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other "]
[]
[" Investment margin   ",null,450,146,303,1,null,null,368,103,263,1]
[" Fees & revenues  ",null,310,209,null,101,null,null,303,209,null,93]
[" Net technical margin  ",null,1274,47,1151,77,null,null,1337,46,1209,82]
[" Expenses  ",null,-1324,-182,-1067,-76,null,null,-1268,-151,-1053,-64]
[" Amortization of value of business in force (gross of tax expenses) ",null,-35,-34,null,-1,null,null,-4,-6,null,2]
[]
[" Underlying earnings before tax from insurance activities ",null,675,186,387,103,null,null,735,201,419,115]
[]
[" Underlying earnings before tax from other activities ",null,107,null,null,null,107,null,36,null,null,null,36]
[]
[" Income tax expenses/benefits ",null,-235,-27,-120,-38,-51,null,-221,-54,-125,-42,-1]
[" Income from affiliates and associates ",null,2,"                     -   ","                     -   ","                     -   ",2,null,7,"                     -   ","                     -   ","                     -   ",7]
[" Minority interests ",null,-1,-1,0,"                     -   ",0,null,-1,0,-1,"                     -   ","                     -   "]
[]
["Underlying earnings Group share",null,549,159,267,64,59,null,556,147,293,73,42]

{"sheet":"9) MA - Belgium","index":10,"n_rows":25,"n_cols":13,"rows_kept":25,"cut":false,"hidden":false,"merged":[[26,0,26,6],[1,0,1,12],[2,0,2,12],[3,0,3,12],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,6,5,6],[4,7,5,7],[4,8,5,8],[4,9,5,9],[4,10,4,12],[5,10,5,12],[7,2,7,6],[7,8,7,12]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" BELGIUM "]
[]
[" (Euro million)  ",null,null,null,null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other ",null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other "]
[]
[" Investment margin   ",null,501,342,156,2,null,null,458,303,154,2]
[" Fees & revenues  ",null,134,134,null,"                     -   ",null,null,127,127,null,"                     -   "]
[" Net technical margin  ",null,787,22,760,5,null,null,856,40,813,4]
[" Expenses  ",null,-890,-224,-655,-11,null,null,-907,-215,-680,-12]
[" Amortization of value of business in force (gross of tax expenses) ",null,-8,-8,null,"                     -   ",null,null,-1,-1,null,"                     -   "]
[]
[" Underlying earnings before tax from insurance activities ",null,524,266,262,-4,null,null,533,253,286,-7]
[]
[" Underlying earnings before tax from other activities ",null,-4,null,null,null,-4,null,-2,null,null,null,-2]
[]
[" Income tax expenses/benefits ",null,-160,-84,-78,1,1,null,-174,-69,-94,2,-14]
[" Income from affiliates and associates ",null,"                     -   ","                     -   ","                     -   ","                     -   ","                     -   ",null,"                     -   ","                     -   ","                     -   ","                     -   ","                     -   "]
[" Minority interests ",null,0,0,"                     -   ","                     -   ","                     -   ",null,0,0,"                     -   ","                     -   ","                     -   "]
[]
["Underlying earnings Group share",null,359,182,184,-3,-3,null,357,184,193,-4,-16]

{"sheet":"10) MA - UK.Ireland","index":11,"n_rows":25,"n_cols":13,"rows_kept":25,"cut":false,"hidden":false,"merged":[[26,0,26,6],[1,0,1,12],[2,0,2,12],[3,0,3,12],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,6,5,6],[4,7,5,7],[4,8,5,8],[4,9,5,9],[4,10,4,12],[5,10,5,12],[7,2,7,6],[7,8,7,12]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" UNITED KINGDOM & IRELAND "]
[]
[" (Euro million)  ",null,null,null,null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other ",null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other "]
[]
[" Investment margin   ",null,243,1,217,26,null,null,220,0,199,21]
[" Fees & revenues  ",null,66,66,null,"                     -   ",null,null,60,60,null,"                     -   "]
[" Net technical margin  ",null,1584,"                     -   ",1035,549,null,null,1483,"                     -   ",942,541]
[" Expenses  ",null,-1507,-64,-972,-471,null,null,-1413,-47,-912,-453]
[" Amortization of value of business in force (gross of tax expenses) ",null,"                     -   ","                     -   ",null,"                     -   ",null,null,"                     -   ","                     -   ",null,"                     -   "]
[]
[" Underlying earnings before tax from insurance activities ",null,386,3,280,103,null,null,350,12,228,109]
[]
[" Underlying earnings before tax from other activities ",null,-12,null,null,null,-12,null,-10,null,null,null,-10]
[]
[" Income tax expenses/benefits ",null,-55,-2,-42,-21,11,null,-58,-4,-38,-20,4]
[" Income from affiliates and associates ",null,"                     -   ","                     -   ","                     -   ","                     -   ","                     -   ",null,"                     -   ","                     -   ","                     -   ","                     -   ","                     -   "]
[" Minority interests ",null,0,0,0,"                     -   ",0,null,0,0,0,"                     -   ",0]
[]
["Underlying earnings Group share",null,320,1,237,82,-1,null,282,8,191,89,-6]

{"sheet":"11) MA - Spain","index":12,"n_rows":23,"n_cols":11,"rows_kept":23,"cut":false,"hidden":false,"merged":[[5,9,5,10],[7,2,7,5],[7,7,7,10],[1,0,1,10],[2,0,2,10],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,6,5,6],[4,7,5,7],[4,8,5,8],[4,9,4,10]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" SPAIN "]
[]
[" (Euro million)  ",null,null,null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," Life & Savings "," Property & Casualty  "," Health ",null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "]
[]
[" Investment margin   ",null,139,40,97,2,null,136,44,91,1]
[" Fees & revenues  ",null,79,79,null,"                     -   ",null,81,81,null,"                     -   "]
[" Net technical margin  ",null,522,29,452,40,null,548,27,474,48]
[" Expenses  ",null,-550,-86,-435,-29,null,-555,-87,-434,-34]
[" Amortization of value of business in force (gross of tax expenses) ",null,-3,-3,null,"                     -   ",null,-3,-3,null,"                     -   "]
[]
[" Underlying earnings before tax from insurance activities ",null,185,58,114,13,null,207,61,131,15]
[]
[" Income tax expenses/benefits ",null,-44,-14,-27,-3,null,-48,-15,-29,-4]
[" Income from affiliates and associates ",null,"                     -   ","                     -   ","                     -   ","                     -   ",null,"                     -   ","                     -   ","                     -   ","                     -   "]
[" Minority interests ",null,0,0,0,"                     -   ",null,0,0,0,"                     -   "]
[]
["Underlying earnings Group share",null,140,44,87,10,null,159,46,102,11]

{"sheet":"12) MA - Italy","index":13,"n_rows":23,"n_cols":13,"rows_kept":23,"cut":false,"hidden":false,"merged":[[7,2,7,6],[7,8,7,12],[1,0,1,12],[2,0,2,12],[3,0,3,12],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,6,5,6],[4,7,5,7],[4,8,5,8],[4,9,5,9],[4,10,4,12],[5,10,5,12]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" ITALY "]
[]
[" (Euro million)  ",null,null,null,null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other ",null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other "]
[]
[" Investment margin   ",null,250,144,106,"                     -   ",null,null,248,148,99,2]
[" Fees & revenues  ",null,288,288,null,"                     -   ",null,null,255,255,null,"                     -   "]
[" Net technical margin  ",null,594,49,526,20,null,null,585,55,506,23]
[" Expenses  ",null,-766,-288,-458,-19,null,null,-744,-275,-449,-20]
[" Amortization of value of business in force (gross of tax expenses) ",null,-3,-3,null,"                     -   ",null,null,-2,-2,null,"                     -   "]
[]
[" Underlying earnings before tax from insurance activities ",null,363,189,174,0,null,null,341,181,156,5]
[]
[" Income tax expenses/benefits ",null,-111,-46,-61,"                     -   ",-3,null,-105,-53,-49,-1,-1]
[" Income from affiliates and associates ",null,"                     -   ","                     -   ","                     -   ","                     -   ","                     -   ",null,"                     -   ","                     -   ","                     -   ","                     -   ","                     -   "]
[" Minority interests ",null,-77,-67,-10,"                     -   ",0,null,-72,-58,-14,"                     -   ","                     -   "]
[]
["Underlying earnings Group share",null,176,76,103,0,-3,null,164,69,92,3,-1]

{"sheet":"13) MA - Asia","index":14,"n_rows":25,"n_cols":13,"rows_kept":25,"cut":false,"hidden":false,"merged":[[7,2,7,6],[7,8,7,12],[1,0,1,12],[2,0,2,12],[3,0,3,12],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,6,5,6],[4,7,5,7],[4,8,5,8],[4,9,5,9],[4,10,4,12],[5,10,5,12]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" ASIA "]
[]
[" (Euro million)  ",null,null,null,null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other ",null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other "]
[]
[" Investment margin   ",null,33,-9,27,14,null,null,35,-15,28,21]
[" Fees & revenues  ",null,1999,1274,null,725,null,null,1948,1249,null,699]
[" Net technical margin  ",null,784,264,352,168,null,null,768,212,362,194]
[" Expenses  ",null,-1651,-868,-322,-461,null,null,-1550,-754,-331,-465]
[" Amortization of value of business in force (gross of tax expenses) ",null,-28,-23,null,-5,null,null,-13,-13,null,0]
[]
[" Underlying earnings before tax from insurance activities ",null,1137,639,57,440,null,null,1187,679,60,448]
[]
[" Underlying earnings before tax from other activities ",null,-2,null,null,null,-2,null,0,null,null,null,0]
[]
[" Income tax expenses/benefits ",null,-242,-107,-9,-118,-7,null,-257,-110,-14,-126,-8]
[" Income from affiliates and associates ",null,160,159,-2,4,"                     -   ",null,166,160,3,2,"                     -   "]
[" Minority interests ",null,-7,-6,0,0,"                     -   ",null,-7,-4,0,-3,"                     -   "]
[]
["Underlying earnings Group share",null,1047,685,46,326,-9,null,1089,726,49,321,-8]

{"sheet":"14) MA - Japan","index":15,"n_rows":23,"n_cols":9,"rows_kept":23,"cut":false,"hidden":false,"merged":[[7,2,7,4],[7,6,7,8],[1,0,1,8],[2,0,2,8],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,5,5,5],[4,6,5,6],[4,7,4,8],[5,7,5,8]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" JAPAN "]
[]
[" (Euro million)  ",null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," Life & Savings "," Health ",null," TOTAL "," Life & Savings "," Health "]
[]
[" Investment margin   ",null,0,-12,12,null,0,-18,18]
[" Fees & revenues  ",null,1327,696,631,null,1278,678,600]
[" Net technical margin  ",null,241,116,125,null,247,104,143]
[" Expenses  ",null,-870,-529,-341,null,-794,-453,-340]
[" Amortization of value of business in force (gross of tax expenses) ",null,-17,-11,-5,null,-12,-12,0]
[]
[" Underlying earnings before tax from insurance activities ",null,682,259,422,null,719,298,421]
[]
[" Income tax expenses/benefits ",null,-195,-77,-118,null,-215,-91,-125]
[" Income from affiliates and associates ",null,"                     -   ","                     -   ","                     -   ",null,"                     -   ","                     -   ","                     -   "]
[" Minority interests ",null,-6,-6,"                     -   ",null,-7,-4,-3]
[]
["Underlying earnings Group share",null,480,176,304,null,497,204,293]

{"sheet":"15) MA - Hong Kong","index":16,"n_rows":23,"n_cols":11,"rows_kept":23,"cut":false,"hidden":false,"merged":[[5,9,5,10],[7,2,7,5],[7,7,7,10],[1,0,1,10],[2,0,2,10],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,6,5,6],[4,7,5,7],[4,8,5,8],[4,9,4,10]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" HONG KONG "]
[]
[" (Euro million)  ",null,null,null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," Life & Savings "," Property & Casualty  "," Health ",null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "]
[]
[" Investment margin   ",null,10,0,8,1,null,11,0,9,2]
[" Fees & revenues  ",null,638,550,null,88,null,624,536,null,89]
[" Net technical margin  ",null,285,140,106,39,null,254,105,106,43]
[" Expenses  ",null,-503,-311,-92,-100,null,-475,-273,-97,-106]
[" Amortization of value of business in force (gross of tax expenses) ",null,-11,-11,null,"                     -   ",null,-1,-1,null,"                     -   "]
[]
[" Underlying earnings before tax from insurance activities ",null,418,367,22,29,null,412,367,19,27]
[]
[" Income tax expenses/benefits ",null,-29,-30,1,0,null,-20,-18,-1,-1]
[" Income from affiliates and associates ",null,"                     -   ","                     -   ","                     -   ","                     -   ",null,"                     -   ","                     -   ","                     -   ","                     -   "]
[" Minority interests ",null,"                     -   ","                     -   ","                     -   ","                     -   ",null,"                     -   ","                     -   ","                     -   ","                     -   "]
[]
["Underlying earnings Group share",null,389,338,22,28,null,392,349,17,26]

{"sheet":"16) MA - Asia High Potential_x000a_  ","index":17,"n_rows":24,"n_cols":11,"rows_kept":24,"cut":false,"hidden":false,"merged":[[5,9,5,10],[7,2,7,5],[7,7,7,10],[1,0,1,10],[2,0,2,10],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,6,5,6],[4,7,5,7],[4,8,5,8],[4,9,4,10]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" ASIA HIGH POTENTIALS "]
[]
[" (Euro million)  ",null,null,null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," Life & Savings "," Property & Casualty  "," Health ",null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "]
[]
[" Investment margin   ",null,5,3,2,0,null,6,4,2,1]
[" Fees & revenues  ",null,34,28,null,5,null,46,36,null,10]
[" Net technical margin  ",null,35,9,24,2,null,28,3,18,6]
[" Expenses  ",null,-75,-28,-29,-18,null,-76,-29,-30,-17]
[" Amortization of value of business in force (gross of tax expenses) ",null,0,0,null,"                     -   ",null,0,0,null,"                     -   "]
[]
[" Underlying earnings before tax from insurance activities ",null,-1,13,-3,-11,null,4,14,-10,0]
[]
[]
[" Income tax expenses/benefits ",null,1,0,1,0,null,1,-1,2,0]
[" Income from affiliates and associates ",null,160,159,-2,4,null,166,160,3,2]
[" Minority interests ",null,0,0,0,"                     -   ",null,0,0,0,"                     -   "]
[]
["Underlying earnings Group share",null,161,171,-4,-7,null,171,173,-5,2]

{"sheet":"17) MA - Asia Direct   ","index":18,"n_rows":23,"n_cols":9,"rows_kept":23,"cut":false,"hidden":false,"merged":[[7,2,7,4],[7,6,7,8],[1,0,1,8],[2,0,2,8],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,5,5,5],[4,6,5,6],[4,7,4,8],[5,7,5,8]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" ASIA - DIRECT "]
[]
[" (Euro million)  ",null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," Property & Casualty  "," Health ",null," TOTAL "," Property & Casualty  "," Health "]
[]
[" Investment margin   ",null,18,18,"                     -   ",null,18,18,"                     -   "]
[" Fees & revenues  ",null,"                     -   ",null,"                     -   ",null,"                     -   ",null,"                     -   "]
[" Net technical margin  ",null,223,222,2,null,240,238,2]
[" Expenses  ",null,-202,-201,-1,null,-206,-204,-2]
[" Amortization of value of business in force (gross of tax expenses) ",null,"                     -   ",null,"                     -   ",null,"                     -   ",null,"                     -   "]
[]
[" Underlying earnings before tax from insurance activities ",null,39,38,0,null,52,52,0]
[]
[" Income tax expenses/benefits ",null,-11,-11,0,null,-14,-14,0]
[" Income from affiliates and associates ",null,"                     -   ","                     -   ","                     -   ",null,"                     -   ","                     -   ","                     -   "]
[" Minority interests ",null,0,0,0,null,0,0,"                     -   "]
[]
["Underlying earnings Group share",null,27,27,0,null,37,37,0]

{"sheet":"18) MA - US ","index":19,"n_rows":27,"n_cols":11,"rows_kept":27,"cut":false,"hidden":false,"merged":[[7,2,7,5],[7,7,7,10],[26,0,26,3],[1,0,1,10],[2,0,2,10],[3,0,3,10],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,5,5,5],[4,6,5,6],[4,7,5,7],[4,8,4,10],[5,8,5,10]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" UNITED STATES "]
[]
[" (Euro million)  ",null,null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," Life & Savings (a) "," Health "," Other ",null," TOTAL "," Life & Savings (a) "," Health "," Other "]
[]
[" Investment margin   ",null,567,570,-3,null,null,543,543,0]
[" Fees & revenues  ",null,2650,2645,6,null,null,2583,2579,3]
[" Net technical margin  ",null,91,106,-15,null,null,-424,-408,-15]
[" Expenses  ",null,-2385,-2359,-26,null,null,-1865,-1850,-15]
[" Amortization of value of business in force (gross of tax expenses) ",null,-10,-10,"                     -   ",null,null,-1,-1,"                     -   "]
[]
[" Underlying earnings before tax from insurance activities ",null,912,951,-39,null,null,836,863,-27]
[]
[" Underlying earnings before tax from other activities ",null,499,null,null,499,null,556,null,null,556]
[]
[" Income tax expenses/benefits ",null,-208,-42,14,-180,null,-7,91,12,-110]
[" Income from affiliates and associates ",null,"                     -   ","                     -   ","                     -   ","                     -   ",null,"                     -   ","                     -   ","                     -   ","                     -   "]
[" Minority interests ",null,-205,0,"                     -   ",-205,null,-250,0,"                     -   ",-250]
[]
["Underlying earnings Group share",null,998,909,-25,114,null,1135,954,-15,195]
[]
[" (a) Reallocation of AXA Corporate Solutions Life Reinsurance Company operations into the Life & Savings activities "]

{"sheet":"19) AM - AUM Breakdown AB ","index":20,"n_rows":23,"n_cols":11,"rows_kept":23,"cut":false,"hidden":false,"merged":[[3,8,4,8],[3,9,4,9],[6,2,6,5],[6,7,6,10],[1,0,1,10],[2,0,2,10],[3,0,4,0],[3,1,4,1],[3,2,4,2],[3,3,4,3],[3,4,4,4],[3,5,4,5],[3,6,4,6],[3,7,4,7]]}
["Back to Summary"]
["ASSET MANAGEMENT - AUM BREAKDOWN "]
["AB"]
["(Euro billion) ",null,null,null,null,null,null,null,null,null,"AXA Consolidated"]
[null,null,null,null,null,null,null,null,null,null,"Financial Statements"]
[]
[null,null,"Period ended  December 31, 2016",null,null,null,null,"Period ended  December 31, 2017"]
[null,null,"Total","Institutional","Retail","Private clients",null,"Total","Institutional","Retail","Private clients"]
[]
["Total AUM",null,486,258,152,77,null,468,231,161,77]
["  of which equity instruments ",null,137,56,42,39,null,116,28,48,40]
["  of which debt instruments ",null,244,144,70,30,null,240,137,74,29]
["  of which other",null,105,57,40,8,null,112,66,38,8]
[]
["AUM as of Period ended N-1",null,455,242,142,71,null,486,258,152,77]
["Gross sales",null,66,20,37,9,null,70,12,48,10]
["Redemptions",null,-59,-14,-37,-8,null,-54,-10,-34,-9]
["Others",null,-18,-13,-5,0,null,-4,1,-6,0]
["Net sales",null,-12,-8,-4,0,null,12,3,8,1]
["Change in scope",null,2,2,0,0,null,-21,-21,"                                 -   ","                                 -   "]
["Market effect",null,26,13,10,3,null,53,23,21,10]
["Currency impact",null,14,8,5,2,null,-62,-32,-20,-10]
["AUM as of the end of the period",null,486,258,152,77,null,468,231,161,77]

{"sheet":"20) MA - AB","index":21,"n_rows":29,"n_cols":5,"rows_kept":29,"cut":false,"hidden":false,"merged":[[1,0,1,4],[2,0,2,4],[3,0,4,0],[3,1,4,1],[3,2,3,4],[4,2,4,4]]}
["Back to Summary"]
["MARGIN ANALYSIS"]
["AB"]
["(Euro million) ",null,"AXA Consolidated"]
[null,null,"Financial statements"]
[]
[null,null," Period ended December 31, 2016",null,"Period ended December 31, 2017"]
[]
["Gross revenues - after intercompany eliminations",null,2530,null,2700]
[]
["Gross revenues - before intercompany eliminations",null,2642,null,2816]
["o/w Management fees",null,1720,null,1864]
["o/w Distribution fees",null,348,null,365]
[]
["General expenses",null,-2021,null,-2160]
["o/w Fees retroceded",null,-295,null,-372]
["Net investment result",null,-5,null,30]
[]
["Underlying earnings before tax",null,616,null,685]
[]
["Income tax expenses / benefits",null,-220,null,-152]
["Minority interests",null,-205,null,-250]
["Income from affiliates and associates",null,"-",null,"-"]
[]
["Underlying earnings Group share",null,191,null,283]
[]
["Average Assets under Management (in Euro billion)",null,464,null,469]
["Asset management fee bps",null,37.1,null,39.799999999999997]
["Underlying cost income ratio",null,0.73399999999999999,null,0.71799999999999997]

{"sheet":"21) MA - International   ","index":22,"n_rows":25,"n_cols":13,"rows_kept":25,"cut":false,"hidden":false,"merged":[[26,0,26,6],[1,0,1,12],[2,0,2,12],[3,0,3,12],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,6,5,6],[4,7,5,7],[4,8,5,8],[4,9,5,9],[4,10,4,12],[5,10,5,12],[7,2,7,6],[7,8,7,12]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" INTERNATIONAL "]
[]
[" (Euro million)  ",null,null,null,null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other ",null," TOTAL "," Life & Savings "," Property & Casualty  "," Health "," Other "]
[]
[" Investment margin   ",null,357,59,278,21,null,null,375,63,289,22]
[" Fees & revenues  ",null,351,322,null,28,null,null,420,395,null,26]
[" Net technical margin  ",null,1341,106,1004,231,null,null,1396,92,1040,264]
[" Expenses  ",null,-1757,-412,-1052,-293,null,null,-1859,-456,-1095,-309]
[" Amortization of value of business in force (gross of tax expenses) ",null,-4,-4,null,0,null,null,-3,-3,null,"                     -   "]
[]
[" Underlying earnings before tax from insurance activities ",null,288,72,230,-13,null,null,330,92,235,3]
[]
[" Underlying earnings before tax from other activities ",null,68,null,null,null,68,null,49,null,null,null,49]
[]
[" Income tax expenses/benefits ",null,-80,-20,-45,-2,-14,null,-91,-33,-43,-1,-15]
[" Income from affiliates and associates ",null,47,6,41,0,0,null,86,6,80,"                     -   ",0]
[" Minority interests ",null,-35,0,-39,4,0,null,-37,2,-35,-4,0]
[]
["Underlying earnings Group share",null,288,58,187,-12,54,null,337,67,238,-2,34]

{"sheet":"22) MA - Transversal  ","index":23,"n_rows":27,"n_cols":11,"rows_kept":27,"cut":false,"hidden":false,"merged":[[5,8,5,10],[7,2,7,5],[7,7,7,10],[26,0,26,6],[1,0,1,10],[2,0,2,10],[3,0,3,10],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,5,5,5],[4,6,5,6],[4,7,5,7],[4,8,4,10]]}
["Back to Summary"]
["  MARGIN ANALYSIS "]
[" TRANSVERSAL & CENTRAL HOLDINGS "]
[]
[" (Euro million)  ",null,null,null,null,null,null,null," AXA Consolidated "]
[null,null,null,null,null,null,null,null," Financial statements "]
[]
[null,null," Period ended December 31, 2016 (Restated) ",null,null,null,null," Period ended December 31, 2017 "]
[null,null," TOTAL "," AXA Corporate Solutions Assurance "," AXA Assistance "," Other (a) ",null," TOTAL "," AXA Corporate Solutions Assurance "," AXA Assistance "," Other (a) "]
[]
[" Investment margin   ",null,254,182,4,68,null,241,176,4,61]
[" Fees & revenues  ",null,14,null,null,14,null,14,null,null,14]
[" Net technical margin  ",null,1125,383,564,178,null,1080,323,599,158]
[" Expenses  ",null,-1105,-410,-535,-161,null,-1128,-422,-560,-146]
[" Amortization of value of business in force (gross of tax expenses) ",null,"                      -   ",null,null,"                      -   ",null,"                      -   ",null,null,"                      -   "]
[]
[" Underlying earnings before tax from insurance activities ",null,288,155,34,100,null,207,78,43,86]
[]
[" Underlying earnings before tax from other activities ",null,-598,null,null,-598,null,-623,null,null,-623]
[]
[" Income tax expenses/benefits ",null,-30,-32,-22,23,null,95,-27,-16,138]
[" Income from affiliates and associates ",null,12,"                      -   ",1,11,null,18,"                      -   ",1,18]
[" Minority interests ",null,-7,-2,0,-5,null,-10,-1,0,-9]
[]
["Underlying earnings Group share",null,-335,122,13,-470,null,-313,50,27,-391]
[]
[" (a) Other corresponds to AXA Investment Managers, AXA Art, AXA Liabilities Managers, AXA Global Re, AXA Life Europe, AXA SA and other Central Holdings "]

{"sheet":"23) AM - AUM Breakdown IM","index":24,"n_rows":23,"n_cols":9,"rows_kept":23,"cut":false,"hidden":false,"merged":[[6,2,6,4],[6,6,6,8],[1,0,1,8],[2,0,2,8],[3,0,4,0],[3,1,4,1],[3,2,4,2],[3,3,4,3],[3,4,4,4],[3,5,4,5],[3,6,4,6],[3,7,4,7]]}
["Back to Summary"]
["ASSET MANAGEMENT - AUM BREAKDOWN "]
["AXA INVESTMENT MANAGERS"]
["(Euro billion) ",null,null,null,null,null,null,null,"AXA Consolidated"]
[null,null,null,null,null,null,null,null,"Financial Statements"]
[]
[null,null,"Period ended  December 31, 2016",null,null,null,"Period ended  December 31, 2017"]
[null,null,"TOTAL","Institutional","Retail",null,"TOTAL","Institutional","Retail"]
[]
["Total AUM",null,717,618,99,null,746,629,117]
["  of which equity instruments ",null,72,41,31,null,79,39,40]
["  of which debt instruments ",null,456,401,55,null,484,420,64]
["  of which other",null,189,175,14,null,183,170,13]
[]
["AUM as of Period ended N-1",null,669,534,135,null,717,618,99]
["Gross sales",null,297,241,56,null,207,139,67]
["Redemptions",null,-241,-193,-48,null,-199,-142,-56]
["Others",null,"                                 -   ","                                 -   ","                                 -   ",null,0,0,"                                 -   "]
["Net sales",null,56,49,8,null,8,-3,11]
["Change in scope",null,-18,24,-41,null,20,17,4]
["Market effect",null,18,15,3,null,21,15,7]
["Currency impact",null,-9,-4,-5,null,-21,-17,-4]
["AUM as of the end of the period",null,717,618,99,null,746,629,117]

{"sheet":"24) MA - IM ","index":25,"n_rows":29,"n_cols":5,"rows_kept":29,"cut":false,"hidden":false,"merged":[[1,0,1,4],[2,0,2,4],[3,0,4,0],[3,1,4,1],[3,2,3,4],[4,2,4,4]]}
["Back to Summary"]
["MARGIN ANALYSIS"]
["AXA INVESTMENT MANAGERS"]
["(Euro million) ",null,"AXA Consolidated"]
[null,null,"Financial statements"]
[]
[null,null," Period ended December 31, 2016",null,"Period ended December 31, 2017"]
[]
["Gross revenues - after intercompany eliminations",null,1180,null,1276]
[]
["Gross revenues - before intercompany eliminations",null,1545,null,1604]
["o/w Management fees",null,1053,null,1126]
["o/w Distribution fees",null,338,null,320]
[]
["General expenses",null,-1212,null,-1229]
["o/w Fees retroceded",null,-338,null,-320]
["Net investment result",null,-17,null,-22]
[]
["Underlying earnings before tax",null,316,null,353]
[]
["Income tax expenses / benefits",null,-96,null,-104]
["Minority interests",null,-5,null,-9]
["Income from affiliates and associates",null,11,null,18]
[]
["Underlying earnings Group share",null,225,null,257]
[]
["Average Assets under Management (in Euro billion)",null,595,null,630]
["Asset management fee bps",null,17.7,null,17.899999999999999]
["Underlying cost income ratio",null,0.72399999999999998,null,0.70799999999999996]

{"sheet":"25) Inv Ass & NII - GRP(N-1)","index":26,"n_rows":47,"n_cols":10,"rows_kept":47,"cut":false,"hidden":false,"merged":[[7,0,7,1],[1,0,1,9],[2,0,2,9],[3,0,3,9],[4,8,4,9],[5,8,5,9],[38,0,38,1],[14,0,14,1],[15,0,15,1],[16,0,16,1],[19,0,20,0],[22,0,23,0],[27,0,27,1],[28,0,28,1],[32,0,32,1],[34,0,34,1],[36,0,36,1],[37,0,37,1],[46,0,46,9],[39,0,39,1],[40,0,40,1],[42,0,42,1],[43,0,43,9],[44,0,44,9],[45,0,45,9]]}
["Back to Summary"]
["INVESTED ASSETS & NET INVESTMENT INCOME"]
["GROUP"]
["Period ended December 31, 2016 (Restated) "]
[null,null,null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million) ",null,null,null,null,null,null,null,"Financial Statements "]
[]
["Net of minority interests on consolidated investment funds ",null,null,"TOTAL","France","Europe","Asia","United States","International","Transversal & Central Holdings (a)"]
[]
["Debt instruments","Carrying value ",null,440845,120571,197781,50582,52381,13326,6204]
[" ","Fair value ",null,441064,120590,197980,50582,52381,13326,6205]
[" ","Net investment income",null,12404,3700,5278,1112,1698,427,190]
["Equity instruments (b)","Fair value ",null,24039,9066,9931,2236,187,817,1802]
[" ","Net investment income",null,805,228,368,122,11,28,49]
["Non consolidated investment funds available for sale ",null,null,9122,1361,6017,894,"-",698,151]
["Non consolidated investment funds under fair value option ",null,null,4797,919,1361,1132,1340,11,32]
["Non consolidated investment funds Trading ",null,null,615,"-",0,"-",568,"-",48]
["Total Non consolidated investment funds ","Fair value ",null,14534,2280,7378,2027,1908,710,231]
[null,"Net investment income",null,387,55,203,50,17,34,29]
["Investment in real estate properties  (c)  ","Carrying value ",null,21504,7990,12747,345,45,198,179]
[null,"Fair value ",null,30411,11738,17703,400,61,335,173]
[" ","Net investment income",null,713,260,410,10,14,11,8]
["Mortgage loans and other loans","Carrying value ",null,63317,11057,19172,1434,13065,18428,160]
[null,"Fair value ",null,66343,11080,20488,1437,12922,20255,160]
[" ","Net investment income",null,1511,128,593,65,634,13,77]
["Other investments ","Fair value ",null,9802,3175,5357,1337,-106,-101,140]
[null,"Net investment income",null,-580,152,-304,1,-458,35,-6]
["Assets backing contracts where the financial risk is borne by policyholders ",null,null,175280,31723,21810,10703,107291,2610,1143]
["Cash and cash equivalents",null,null,26314,3826,4586,3876,6403,2152,5471]
["Invested assets ","Carrying value ",null,775636,189688,278763,72540,181174,38141,15331]
[null,"Fair value ",null,787787,193479,285234,72598,181047,40105,15325]
[null,"Net investment income",null,15241,4522,6548,1360,1916,548,347]
["Unrealized capital gains and losses on assets at cost (A) (d)",null,null,12151,3790,6471,58,-127,1964,-6]
[]
["Unrealized capital gains and losses recorded through shareholders' equity (Gross) "]
[]
["Debt instruments ",null,null,49049,19232,23984,4450,385,458,540]
["Equity instruments (b)",null,null,3816,1420,1752,252,1,147,244]
["Non consolidated investment funds available for sale ",null,null,985,90,787,-6,"-",91,23]
["Loans ",null,null,"-","-","-","-","-","-","-"]
["Total unrealized capital gains recorded through shareholders' equity (B) ",null,null,53850,20742,26523,4695,386,696,807]
[]
["Total unrealized capital gains and losses (A) + (B) ",null,null,66001,24532,32994,4753,260,2660,801]
["(a) Including 100% of some third party real estate and CDO funds operated by AXA Investment Managers but consolidated in AXA invested assets under IFRS rules and for which the group hold only a minority interest."]
["(b) Including investments in listed equities, participating interests, hedge funds and private equities."]
["(c) Includes share of minority interests from consolidated real estate funds and infrastructure investments."]
["(d) Excluding unrealized gains and losses on assets held for sale."]

{"sheet":"26) Inv Ass & NII - GRP(N)","index":27,"n_rows":49,"n_cols":10,"rows_kept":49,"cut":false,"hidden":false,"merged":[[22,0,23,0],[1,0,1,9],[2,0,2,9],[3,0,3,9],[4,8,4,9],[5,8,5,9],[7,0,7,1],[12,0,12,1],[14,0,14,1],[15,0,15,1],[16,0,16,1],[19,0,20,0],[43,0,43,9],[27,0,27,1],[28,0,28,1],[29,0,30,0],[32,0,32,1],[34,0,34,1],[36,0,36,1],[37,0,37,1],[38,0,38,1],[39,0,39,1],[40,0,40,1],[42,0,42,1],[44,0,44,9],[45,0,45,9],[46,0,46,9],[47,0,47,9],[48,0,48,9]]}
["Back to Summary"]
["INVESTED ASSETS & NET INVESTMENT INCOME"]
["GROUP"]
["Period ended December 31, 2017"]
[null,null,null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million) ",null,null,null,null,null,null,null,"Financial Statements "]
[]
["Net of minority interests on consolidated investment funds ",null,null,"TOTAL","France","Europe","Asia","United States","International","Transversal & Central Holdings (a)"]
[]
["Debt instruments (b) ","Carrying value ",null,425904,121142,182780,49797,54624,11873,5688]
[null,"Fair value ",null,426124,121181,182955,49802,54624,11873,5689]
[null,"Net investment income",null,11437,3496,4791,969,1564,445,173]
["Equity instruments (c)",null,null,25925,9584,10849,2637,177,754,1925]
[null,"Net investment income",null,1128,295,427,320,-1,32,56]
["Non consolidated investment funds available for sale ",null,null,9228,1682,5789,680,11,927,139]
["Non consolidated investment funds under fair value option ",null,null,4243,520,1130,1176,1315,69,32]
["Non consolidated investment funds Trading ",null,null,510,"-",0,"-",495,"-",15]
["Total Non consolidated investment funds ","Fair value ",null,13982,2202,6920,1857,1821,996,186]
[null,"Net investment income",null,410,88,213,27,39,31,12]
["Investment in real estate properties (d) (e) ","Carrying value ",null,23800,9823,12577,318,161,199,723]
[null,"Fair value ",null,33530,13964,17918,385,172,357,733]
[null,"Net investment income",null,764,293,426,11,6,9,20]
["Mortgage loans and other loans (e) (b)","Carrying value ",null,61242,10153,17971,1114,12384,19478,143]
[null,"Fair value ",null,63929,10154,18929,1114,12350,21239,143]
[null,"Net investment income",null,1355,66,499,56,653,21,58]
["Other investments ","Fair value ",null,11771,4580,5530,1284,44,-54,387]
[null,"Net investment income",null,-2068,150,-300,2,-1954,19,15]
["Assets backing contracts where the financial risk is borne by policyholders ",null,null,174942,35102,22496,9592,103739,3000,1013]
["Cash and cash equivalents",null,null,23961,3502,7307,2671,4973,2000,3509]
["Invested assets ","Carrying value ",null,761527,196087,266429,69269,177922,38246,13573]
[null,"Fair value ",null,774164,200270,272905,69340,177900,40165,13585]
[null,"Net investment income",null,13026,4388,6057,1384,306,556,335]
["Unrealized capital gains and losses on assets at cost (A) (f)",null,null,12637,4182,6475,71,-23,1919,12]
[]
["Unrealized capital gains and losses recorded through shareholders' equity (Gross) "]
[]
["Debt instruments ",null,null,44060,17330,20415,3955,1473,424,461]
["Equity instruments (c)",null,null,4747,1710,2129,440,2,172,294]
["Non consolidated investment funds available for sale ",null,null,1131,156,807,59,0,89,20]
["Loans ",null,null,"-","-","-","-","-","-","-"]
["Total unrealized capital gains recorded through shareholders' equity (B) ",null,null,49937,19197,23352,4454,1475,685,775]
[]
["Total unrealized capital gains and losses (A) + (B) ",null,null,62574,23379,29827,4525,1452,2603,787]
["(a) Including 100% of some third party real estate and CDO funds operated by AXA Investment Managers but consolidated in AXA invested assets under IFRS rules and for which the group hold only a minority interest."]
["(b) On January 1, 2017, Infrastructure and mid-cap loans were reclassified from Loans at cost to Debt instruments (at cost) that are not quoted in an active market for a total of € 1.6bn."]
["(c) Including investments in listed equities, participating interests, hedge funds and private equities."]
["(d) Includes share of minority interests from consolidated real estate funds and also includes infrastructure investments."]
["(e) On January 1, 2017, Real estate loans were reclassified from Loans at cost to Investment in real estate properties at amortized cost for a total of €0.5bn."]
["(f) Excluding unrealized gains and losses on assets held for sale."]

{"sheet":"27) Inv Ass & NII - EUR(N-1)","index":28,"n_rows":47,"n_cols":10,"rows_kept":47,"cut":false,"hidden":false,"merged":[[5,8,5,9],[1,0,1,9],[2,0,2,9],[3,0,3,9],[4,3,4,4],[4,8,4,9],[37,0,37,1],[7,0,7,1],[14,0,14,1],[15,0,15,1],[16,0,16,1],[19,0,20,0],[22,0,23,0],[27,0,27,1],[28,0,28,1],[32,0,32,1],[34,0,34,1],[36,0,36,1],[45,0,45,9],[46,0,46,9],[38,0,38,1],[39,0,39,1],[40,0,40,1],[42,0,42,1],[43,0,43,9],[44,0,44,9]]}
["Back to Summary"]
["INVESTED ASSETS & NET INVESTMENT INCOME"]
["EUROPE"]
["Period ended December 31, 2016 (Restated) "]
[null,null,null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million) ",null,null,null,null,null,null,null,"Financial Statements "]
[]
["Net of minority interests on consolidated investment funds ",null,null,"TOTAL","Switzerland","Germany","Belgium","United Kingdom & Ireland","Spain","Italy"]
[]
["Debt instruments (a)","Carrying value ",null,197781,57434,69202,35771,6726,8956,19690]
[" ","Fair value ",null,197980,57595,69233,35779,6726,8956,19691]
[" ","Net investment income",null,5278,949,2063,1133,224,304,605]
["Equity instruments (b)","Fair value ",null,9931,3299,3386,2183,374,136,553]
[" ","Net investment income",null,368,113,125,83,21,6,19]
["Non consolidated investment funds available for sale ",null,null,6017,3043,212,96,320,516,1830]
["Non consolidated investment funds under fair value option ",null,null,1361,540,516,235,5,44,21]
["Non consolidated investment funds Trading ",null,null,0,"-",0,"-","-","-","-"]
["Total Non consolidated investment funds ","Fair value ",null,7378,3583,729,330,324,561,1851]
[null,"Net investment income",null,203,104,27,10,20,12,31]
["Investment in real estate properties  (c)  ","Carrying value ",null,12747,8458,1684,1934,168,245,260]
[null,"Fair value ",null,17703,11766,2184,2931,189,296,339]
[" ","Net investment income",null,410,245,54,86,7,10,7]
["Mortgage loans and other loans (a)","Carrying value ",null,19172,10182,6800,1790,158,108,134]
[null,"Fair value ",null,20488,10677,7513,1896,157,112,134]
[" ","Net investment income",null,593,196,249,64,71,10,3]
["Other investments ","Fair value ",null,5357,2215,1221,778,479,137,528]
[null,"Net investment income",null,-304,-119,-68,-9,-62,-4,-42]
["Assets backing contracts where the financial risk is borne by policyholders ",null,null,21810,1905,6100,2423,"-",677,10704]
["Cash and cash equivalents",null,null,4586,639,1149,777,1462,94,466]
["Invested assets ","Carrying value ",null,278763,87713,90271,45987,9691,10915,34186]
[null,"Fair value ",null,285234,91677,91514,47098,9711,10970,34265]
[null,"Net investment income",null,6548,1487,2451,1366,281,339,623]
["Unrealized capital gains and losses on assets at cost (A) (d)",null,null,6471,3964,1243,1111,20,55,79]
[]
["Unrealized capital gains and losses recorded through shareholders' equity (Gross) "]
[]
["Debt instruments ",null,null,23984,3331,9796,6798,339,1418,2302]
["Equity instruments (a)",null,null,1752,665,505,361,63,22,135]
["Non consolidated investment funds available for sale ",null,null,787,515,40,35,27,76,94]
["Loans ",null,null,"-","-","-","-","-","-","-"]
["Total unrealized capital gains recorded through shareholders' equity (B) ",null,null,26523,4510,10341,7194,429,1517,2532]
[]
["Total unrealized capital gains and losses (A) + (B) ",null,null,32994,8474,11584,8305,449,1572,2611]
["(a) On January 1, 2017, Infrastructure and mid-cap loans were reclassified from Loans at cost to Debt instruments (at cost) that are not quoted in an active market for a total of € 0.5bn."]
["(b) Including investments in listed equities, participating interests, hedge funds and private equities."]
["(c) Includes share of minority interests from consolidated real estate funds and infrastructure investments."]
["(d) Excluding unrealized gains and losses on assets held for sale."]

{"sheet":"28) Inv Ass & NII - EUR(N)","index":29,"n_rows":47,"n_cols":10,"rows_kept":47,"cut":false,"hidden":false,"merged":[[5,8,5,9],[1,0,1,9],[2,0,2,9],[3,0,3,9],[4,3,4,4],[4,8,4,9],[36,0,36,1],[7,0,7,1],[12,0,12,1],[14,0,14,1],[15,0,15,1],[16,0,16,1],[19,0,20,0],[22,0,23,0],[27,0,27,1],[28,0,28,1],[32,0,32,1],[34,0,34,1],[44,0,44,9],[45,0,45,9],[46,0,46,9],[37,0,37,1],[38,0,38,1],[39,0,39,1],[40,0,40,1],[42,0,42,1],[43,0,43,9]]}
["Back to Summary"]
["INVESTED ASSETS & NET INVESTMENT INCOME"]
["EUROPE"]
["Period ended December 31, 2017"]
[null,null,null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million) ",null,null,null,null,null,null,null,"Financial Statements "]
[]
["Net of minority interests on consolidated investment funds ",null,null,"TOTAL","Switzerland","Germany","Belgium","United Kingdom & Ireland","Spain","Italy"]
[]
["Debt instruments (a) ","Carrying value ",null,182780,49864,64153,33824,6975,8300,19663]
[null,"Fair value ",null,182955,49989,64182,33845,6975,8300,19664]
[null,"Net investment income",null,4791,829,1888,1019,212,283,560]
["Equity instruments (b)",null,null,10849,3580,3825,2296,411,148,589]
[null,"Net investment income",null,427,150,148,77,30,2,21]
["Non consolidated investment funds available for sale ",null,null,5789,2906,169,206,497,504,1507]
["Non consolidated investment funds under fair value option ",null,null,1130,489,382,194,13,33,19]
["Non consolidated investment funds Trading ",null,null,0,"-",0,"-","-","-","-"]
["Total Non consolidated investment funds ","Fair value ",null,6920,3395,551,399,510,537,1526]
[null,"Net investment income",null,213,99,21,11,18,21,42]
["Investment in real estate properties (c) ","Carrying value ",null,12577,7882,1770,2098,205,252,370]
[null,"Fair value ",null,17918,11469,2316,3132,238,305,457]
[null,"Net investment income",null,426,212,107,87,5,7,9]
["Mortgage loans and other loans (a)","Carrying value ",null,17971,9620,6734,1224,132,48,212]
[null,"Fair value ",null,18929,9937,7295,1305,132,48,212]
[null,"Net investment income",null,499,193,226,48,21,7,4]
["Other investments ","Fair value ",null,5530,2306,1490,613,425,87,609]
[null,"Net investment income",null,-300,-80,-105,-14,-55,-8,-38]
["Assets backing contracts where the financial risk is borne by policyholders ",null,null,22496,1727,6341,2215,"-",787,11425]
["Cash and cash equivalents",null,null,7307,1509,2348,2134,740,178,398]
["Invested assets ","Carrying value ",null,266429,79883,87213,44802,9399,10340,34792]
[null,"Fair value ",null,272905,83912,88349,45940,9431,10392,34881]
[null,"Net investment income",null,6057,1404,2285,1227,231,312,598]
["Unrealized capital gains and losses on assets at cost (A) (d)",null,null,6475,4029,1136,1137,32,53,89]
[]
["Unrealized capital gains and losses recorded through shareholders' equity (Gross) "]
[]
["Debt instruments ",null,null,20415,2922,8012,6111,329,1204,1838]
["Equity instruments (a)",null,null,2129,934,543,395,60,27,170]
["Non consolidated investment funds available for sale ",null,null,807,565,17,40,23,85,78]
["Loans ",null,null,"-","-","-","-","-","-","-"]
["Total unrealized capital gains recorded through shareholders' equity (B) ",null,null,23352,4422,8572,6545,412,1315,2086]
[]
["Total unrealized capital gains and losses (A) + (B) ",null,null,29827,8450,9708,7683,444,1368,2174]
["(a) On January 1, 2017, Infrastructure and mid-cap loans were reclassified from Loans at cost to Debt instruments (at cost) that are not quoted in an active market for a total of € 0.5bn."]
["(b) Including investments in listed equities, participating interests, hedge funds and private equities."]
["(c) Includes share of minority interests from consolidated real estate funds and infrastructure investments."]
["(d) Excluding unrealized gains and losses on assets held for sale."]

{"sheet":"29) Inv Ass & NII ASIA(N-1)","index":30,"n_rows":46,"n_cols":8,"rows_kept":46,"cut":false,"hidden":false,"merged":[[32,0,32,1],[1,0,1,7],[2,0,2,7],[3,0,3,7],[7,0,7,1],[14,0,14,1],[15,0,15,1],[16,0,16,1],[19,0,20,0],[22,0,23,0],[27,0,27,1],[28,0,28,1],[42,0,42,1],[43,0,43,7],[44,0,44,7],[45,0,45,7],[34,0,34,1],[36,0,36,1],[37,0,37,1],[38,0,38,1],[39,0,39,1],[40,0,40,1]]}
["Back to Summary"]
["INVESTED ASSETS & NET INVESTMENT INCOME"]
["ASIA"]
["Period ended December 31, 2016 (Restated) "]
[null,null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million) ",null,null,null,null,null,null,"Financial Statements "]
[]
["Net of minority interests on consolidated investment funds ",null,null,"Total","Japan","Hong Kong ","Asia High Potentials","Asia - Direct"]
[]
["Debt instruments","Carrying value ",null,50582,39051,10649,168,714]
[" ","Fair value ",null,50582,39051,10649,168,714]
[" ","Net investment income",null,1112,620,463,11,18]
["Equity instruments (a)","Fair value ",null,2236,931,1250,8,0]
[" ","Net investment income",null,122,56,66,0,"-"]
["Non consolidated investment funds available for sale ",null,null,894,322,419,0,154]
["Non consolidated investment funds under fair value option ",null,null,1132,988,145,0,"-"]
["Non consolidated investment funds Trading ",null,null,"-","-","-","-","-"]
["Total Non consolidated investment funds ","Fair value ",null,2027,1309,564,0,154]
[null,"Net investment income",null,50,22,28,"-","-"]
["Investment in real estate properties  (b)  ","Carrying value ",null,345,295,50,0,"-"]
[null,"Fair value ",null,400,351,49,0,"-"]
[" ","Net investment income",null,10,10,"-","-","-"]
["Mortgage loans and other loans","Carrying value ",null,1434,1191,239,4,0]
[null,"Fair value ",null,1437,1194,239,4,0]
[" ","Net investment income",null,65,49,16,0,0]
["Other investments ","Fair value ",null,1337,1137,200,0,"-"]
[null,"Net investment income",null,1,15,-14,0,0]
["Assets backing contracts where the financial risk is borne by policyholders ",null,null,10703,6997,3480,226,"-"]
["Cash and cash equivalents",null,null,3876,2015,1519,84,252]
["Invested assets ","Carrying value ",null,72540,52928,17949,490,1121]
[null,"Fair value ",null,72598,52987,17948,490,1121]
[null,"Net investment income",null,1360,773,559,11,18]
["Unrealized capital gains and losses on assets at cost (A) (c)",null,null,58,59,-1,0,"-"]
[]
["Unrealized capital gains and losses recorded through shareholders' equity (Gross) "]
[]
["Debt instruments ",null,null,4450,4712,-279,0,16]
["Equity instruments (a)",null,null,252,195,57,0,"-"]
["Non consolidated investment funds available for sale ",null,null,-6,7,-17,0,4]
["Loans ",null,null,"-","-","-","-","-"]
["Total unrealized capital gains recorded through shareholders' equity (B) ",null,null,4695,4914,-239,0,20]
[]
["Total unrealized capital gains and losses (A) + (B) ",null,null,4753,4973,-240,0,20]
["(a) Including investments in listed equities, participating interests, hedge funds and private equities."]
["(b) Includes share of minority interests from consolidated real estate funds and infrastructure investments."]
["(c) Excluding unrealized gains and losses on assets held for sale."]

{"sheet":"30) Inv Ass & NII ASIA(N)","index":31,"n_rows":46,"n_cols":8,"rows_kept":46,"cut":false,"hidden":false,"merged":[[14,0,14,1],[1,0,1,7],[2,0,2,7],[3,0,3,7],[7,0,7,1],[12,0,12,1],[39,0,39,1],[15,0,15,1],[16,0,16,1],[19,0,20,0],[22,0,23,0],[27,0,27,1],[28,0,28,1],[32,0,32,1],[34,0,34,1],[36,0,36,1],[37,0,37,1],[38,0,38,1],[40,0,40,1],[42,0,42,1],[43,0,43,7],[44,0,44,7],[45,0,45,7]]}
["Back to Summary"]
["INVESTED ASSETS & NET INVESTMENT INCOME"]
["ASIA"]
["Period ended December 31, 2017"]
[null,null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million) ",null,null,null,null,null,null,"Financial Statements "]
[]
["Net of minority interests on consolidated investment funds ",null,null,"Total","Japan","Hong Kong ","Asia High Potentials","Asia - Direct"]
[]
["Debt instruments ","Carrying value ",null,49797,36700,12195,196,706]
[null,"Fair value ",null,49802,36705,12195,196,706]
[null,"Net investment income",null,969,574,365,11,18]
["Equity instruments (a)",null,null,2637,852,1731,7,0]
[null,"Net investment income",null,320,109,211,0,"-"]
["Non consolidated investment funds available for sale ",null,null,680,295,226,0,159]
["Non consolidated investment funds under fair value option ",null,null,1176,778,399,"-","-"]
["Non consolidated investment funds Trading ",null,null,"-","-","-","-","-"]
["Total Non consolidated investment funds ","Fair value ",null,1857,1073,625,0,159]
[null,"Net investment income",null,27,-5,32,"-","-"]
["Investment in real estate properties (b) ","Carrying value ",null,318,265,53,0,"-"]
[null,"Fair value ",null,385,328,57,0,"-"]
[null,"Net investment income",null,11,11,"-",0,"-"]
["Mortgage loans and other loans ","Carrying value ",null,1114,927,184,2,0]
[null,"Fair value ",null,1114,927,184,2,0]
[null,"Net investment income",null,56,41,15,-1,0]
["Other investments ","Fair value ",null,1284,1136,148,0,"-"]
[null,"Net investment income",null,2,23,-20,0,0]
["Assets backing contracts where the financial risk is borne by policyholders ",null,null,9592,6617,2752,223,"-"]
["Cash and cash equivalents",null,null,2671,1651,691,71,246]
["Invested assets ","Carrying value ",null,69269,49221,18378,499,1112]
[null,"Fair value ",null,69340,49288,18382,499,1112]
[null,"Net investment income",null,1384,752,604,10,18]
["Unrealized capital gains and losses on assets at cost (A) (c)",null,null,71,67,4,0,"-"]
[]
["Unrealized capital gains and losses recorded through shareholders' equity (Gross) "]
[]
["Debt instruments ",null,null,3955,3754,191,0,9]
["Equity instruments (a)",null,null,440,226,214,0,"-"]
["Non consolidated investment funds available for sale ",null,null,59,26,29,0,4]
["Loans ",null,null,"-","-","-","-","-"]
["Total unrealized capital gains recorded through shareholders' equity (B) ",null,null,4454,4005,435,0,13]
[]
["Total unrealized capital gains and losses (A) + (B) ",null,null,4525,4072,439,0,13]
["(a) Including investments in listed equities, participating interests, hedge funds and private equities."]
["(b) Includes share of minority interests from consolidated real estate funds and infrastructure investments."]
["(c) Excluding unrealized gains and losses on assets held for sale."]

{"sheet":"31) Inv Ass & NII -TRANS(N-1)","index":32,"n_rows":48,"n_cols":8,"rows_kept":48,"cut":false,"hidden":false,"merged":[[5,6,5,7],[1,0,1,7],[2,0,2,7],[3,0,3,7],[4,3,4,4],[4,6,4,7],[37,0,37,1],[7,0,7,1],[14,0,14,1],[15,0,15,1],[16,0,16,1],[19,0,20,0],[22,0,23,0],[27,0,27,1],[28,0,28,1],[32,0,32,1],[34,0,34,1],[36,0,36,1],[45,0,45,7],[46,0,46,7],[47,0,47,7],[38,0,38,1],[39,0,39,1],[40,0,40,1],[42,0,42,1],[43,0,43,7],[44,0,44,7]]}
["Back to Summary"]
["INVESTED ASSETS & NET INVESTMENT INCOME"]
["TRANSVERSAL & CENTRAL HOLDINGS"]
["Period ended December 31, 2016 (Restated) "]
[null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million) ",null,null,null,null,null,"Financial Statements "]
[]
["Net of minority interests on consolidated investment funds ",null,null,"TOTAL","AXA Investment Managers","AXA Corporate Solutions Assurance","AXA Assistance","Other (e)"]
[]
["Debt instruments","Carrying value ",null,6204,154,3956,128,1965]
[" ","Fair value ",null,6205,154,3957,128,1965]
[" ","Net investment income",null,190,0,147,3,40]
["Equity instruments (b)","Fair value ",null,1802,427,548,14,813]
[" ","Net investment income",null,49,2,21,0,26]
["Non consolidated investment funds available for sale ",null,null,151,"-",51,26,74]
["Non consolidated investment funds under fair value option ",null,null,32,"-",8,19,5]
["Non consolidated investment funds Trading ",null,null,48,"-","-","-",48]
["Total Non consolidated investment funds ","Fair value ",null,231,"-",59,46,127]
[null,"Net investment income",null,29,23,2,1,2]
["Investment in real estate properties  (c)  ","Carrying value ",null,179,"-",53,"-",126]
[null,"Fair value ",null,173,"-",55,"-",118]
[" ","Net investment income",null,8,"-",17,"-",-8]
["Mortgage loans and other loans","Carrying value ",null,160,3,59,0,98]
[null,"Fair value ",null,160,3,59,0,98]
[" ","Net investment income",null,77,1,2,"-",73]
["Other investments ","Fair value ",null,140,1,176,"-",-37]
[null,"Net investment income",null,-6,2,-1,1,-8]
["Assets backing contracts where the financial risk is borne by policyholders ",null,null,1143,"-","-","-",1143]
["Cash and cash equivalents",null,null,5471,605,347,406,4113]
["Invested assets ","Carrying value ",null,15331,1190,5197,594,8349]
[null,"Fair value ",null,15325,1190,5199,594,8341]
[null,"Net investment income",null,347,29,188,5,125]
["Unrealized capital gains and losses on assets at cost (A) (d)",null,null,-6,0,2,"-",-8]
[]
["Unrealized capital gains and losses recorded through shareholders' equity (Gross) "]
[]
["Debt instruments ",null,null,540,0,442,6,92]
["Equity instruments (b)",null,null,244,0,97,0,147]
["Non consolidated investment funds available for sale ",null,null,23,"-",12,0,11]
["Loans ",null,null,"-","-","-","-","-"]
["Total unrealized capital gains recorded through shareholders' equity (B) ",null,null,807,0,551,6,250]
[]
["Total unrealized capital gains and losses (A) + (B) ",null,null,801,0,553,6,242]
["(a) Including 100% of some third party real estate and CDO funds operated by AXA Investment Managers but consolidated in AXA invested assets under IFRS rules and for which the group hold only a minority interest."]
["(b) Including investments in listed equities, participating interests, hedge funds and private equities."]
["(c) Includes share of minority interests from consolidated real estate funds and infrastructure investments."]
["(d) Excluding unrealized gains and losses on assets held for sale."]
["(e) Other includes AXA Assistance, AXA Life Europe, AXA Liabilities Managers, AXA Corporate Solutions Assurance, AXA Global Re and AXA Art. "]

{"sheet":"32) Inv Ass & NII -TRANS(N)","index":33,"n_rows":48,"n_cols":8,"rows_kept":48,"cut":false,"hidden":false,"merged":[[19,0,20,0],[1,0,1,7],[2,0,2,7],[3,0,3,7],[4,3,4,4],[4,6,4,7],[5,6,5,7],[7,0,7,1],[12,0,12,1],[14,0,14,1],[15,0,15,1],[16,0,16,1],[42,0,42,1],[22,0,23,0],[27,0,27,1],[28,0,28,1],[29,0,30,0],[32,0,32,1],[34,0,34,1],[36,0,36,1],[37,0,37,1],[38,0,38,1],[39,0,39,1],[40,0,40,1],[43,0,43,7],[44,0,44,7],[45,0,45,7],[46,0,46,7],[47,0,47,7]]}
["Back to Summary"]
["INVESTED ASSETS & NET INVESTMENT INCOME"]
["TRANSVERSAL & CENTRAL HOLDINGS"]
["Period ended December 31, 2017"]
[null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million) ",null,null,null,null,null,"Financial Statements "]
[]
["Net of minority interests on consolidated investment funds ",null,null,"Total","AXA Investment Managers","AXA Corporate Solutions Assurance","AXA Assistance","Other (e)"]
[]
["Debt instruments ","Carrying value ",null,5688,159,3670,160,1699]
[null,"Fair value ",null,5689,159,3671,160,1699]
[null,"Net investment income",null,173,3,133,3,35]
["Equity instruments (b)",null,null,1925,520,592,3,810]
[null,"Net investment income",null,56,1,28,0,27]
["Non consolidated investment funds available for sale ",null,null,139,"-",60,12,67]
["Non consolidated investment funds under fair value option ",null,null,32,"-",1,21,10]
["Non consolidated investment funds Trading ",null,null,15,"-","-","-",15]
["Total Non consolidated investment funds ","Fair value ",null,186,"-",61,33,93]
[null,"Net investment income",null,12,8,1,1,2]
["Investment in real estate properties (c) ","Carrying value ",null,723,"-",14,"-",709]
[null,"Fair value ",null,733,"-",14,"-",719]
[null,"Net investment income",null,20,"-",21,"-",-1]
["Mortgage loans and other loans ","Carrying value ",null,143,4,24,2,112]
[null,"Fair value ",null,143,4,24,2,112]
[null,"Net investment income",null,58,0,1,0,58]
["Other investments ","Fair value ",null,387,0,254,"-",133]
[null,"Net investment income",null,15,-2,3,1,13]
["Assets backing contracts where the financial risk is borne by policyholders ",null,null,1013,"-","-","-",1013]
["Cash and cash equivalents",null,null,3509,756,442,344,1967]
["Invested assets ","Carrying value ",null,13573,1439,5057,541,6536]
[null,"Fair value ",null,13585,1439,5058,541,6546]
[null,"Net investment income",null,335,10,186,5,134]
["Unrealized capital gains and losses on assets at cost (A) (d)",null,null,12,0,1,"-",10]
[]
["Unrealized capital gains and losses recorded through shareholders' equity (Gross) "]
[]
["Debt instruments ",null,null,461,-1,382,5,76]
["Equity instruments (b)",null,null,294,0,120,0,173]
["Non consolidated investment funds available for sale ",null,null,20,"-",9,0,11]
["Loans ",null,null,"-","-","-","-","-"]
["Total unrealized capital gains recorded through shareholders' equity (B) ",null,null,775,-1,511,5,260]
[]
["Total unrealized capital gains and losses (A) + (B) ",null,null,787,-1,512,5,270]
["(a) Including 100% of some third party real estate and CDO funds operated by AXA Investment Managers but consolidated in AXA invested assets under IFRS rules and for which the group hold only a minority interest."]
["(b) Including investments in listed equities, participating interests, hedge funds and private equities."]
["(c) Includes share of minority interests from consolidated real estate funds infrastructure investments."]
["(d) Excluding unrealized gains and losses on assets held for sale."]
["(e) Other includes AXA Assistance, AXA Life Europe, AXA Liabilities Managers, AXA Corporate Solutions Assurance, AXA Global Re and AXA Art. "]

{"sheet":"33) CoR - GROUP (N-1)","index":34,"n_rows":32,"n_cols":9,"rows_kept":32,"cut":false,"hidden":false,"merged":[[1,0,1,8],[2,0,2,8],[3,0,3,8],[4,7,4,8],[5,7,5,8]]}
["Back to Summary"]
["COMBINED RATIO ANALYSIS & NET NEW CONTRACTS"]
["GROUP"]
["Period ended December 31, 2016 (Restated)"]
[null,null,null,null,null,null,null,"AXA Consolidated   "]
["(Euro million) ",null,null,null,null,null,null,"Financial Statements  "]
[]
[null,null,"TOTAL","France","Europe","Asia","United States","International","Transversal & Central Holdings"]
[]
["Property & Casualty"]
["Earned revenues (gross) ",null,31875,7313,15698,1306,null,3712,3845]
["Current accident year loss ratio",null,0.70499999999999996,0.70299999999999996,0.68600000000000005,0.73,null,0.73,0.748]
["o/w Nat Cat impact",null,5.0000000000000001E-3,0.01,5.0000000000000001E-3,3.0000000000000001E-3,null,3.0000000000000001E-3,0]
["All accident year loss ratio ",null,0.69199999999999995,0.68500000000000005,0.67400000000000004,0.73099999999999998,null,0.72899999999999998,0.72799999999999998]
["Expense ratio ",null,0.27200000000000002,0.26500000000000001,0.27700000000000002,0.246,null,0.28299999999999997,0.25800000000000001]
["Combined ratio",null,0.96399999999999997,0.95,0.95099999999999996,0.97699999999999998,null,1.0129999999999999,0.98699999999999999]
[]
["Net new contracts (thous. policy count)"]
["Motor",null,90,-30,60,-98,null,158]
["Household",null,123,-8,104,26,null,0]
[]
["Health"]
["Earned revenues (gross) ",null,11910,3404,4969,2036,55,1281,166]
["All accident year loss ratio ",null,0.78800000000000003,0.81200000000000006,0.86599999999999999,0.56100000000000005,1.1850000000000001,0.79800000000000004,0.50900000000000001]
["Expense ratio ",null,0.16200000000000001,0.17499999999999999,9.7000000000000003E-2,0.22900000000000001,0.46400000000000002,0.22900000000000001,0.39200000000000002]
["Combined ratio",null,0.94899999999999995,0.98699999999999999,0.96299999999999997,0.79100000000000004,1.6479999999999999,1.0269999999999999,0.9]
[]
["Protection"]
["Earned revenues (gross) ",null,21651,3904,9782,4317,2926,722]
["All accident year loss ratio ",null,0.80700000000000005,0.748,0.90900000000000003,0.68899999999999995,0.77300000000000002,0.59699999999999998]
["Expense ratio ",null,0.16300000000000001,0.221,7.3999999999999996E-2,0.17100000000000001,0.313,0.41399999999999998]
["Combined ratio",null,0.97,0.96899999999999997,0.98299999999999998,0.85899999999999999,1.087,1.0109999999999999]

{"sheet":"34) CoR - GROUP (N) ","index":35,"n_rows":32,"n_cols":9,"rows_kept":32,"cut":false,"hidden":false,"merged":[[1,0,1,8],[2,0,2,8],[3,0,3,8],[4,7,4,8],[5,7,5,8]]}
["Back to Summary"]
["COMBINED RATIO ANALYSIS & NET NEW CONTRACTS"]
["GROUP"]
["Period ended December 31, 2017"]
[null,null,null,null,null,null,null,"AXA Consolidated   "]
["(Euro million) ",null,null,null,null,null,null,"Financial Statements  "]
[]
[null,null,"TOTAL","France","Europe","Asia","United States","International","Transversal & Central Holdings"]
[]
["Property & Casualty"]
["Earned revenues (gross) ",null,31854,7233,15662,1310,null,3765,3883]
["Current accident year loss ratio",null,0.70199999999999996,0.69599999999999995,0.68799999999999994,0.72699999999999998,null,0.70599999999999996,0.75800000000000001]
["o/w Nat Cat impact",null,7.0000000000000001E-3,2E-3,5.0000000000000001E-3,6.0000000000000001E-3,null,1.7000000000000001E-2,1.7000000000000001E-2]
["All accident year loss ratio ",null,0.69,0.67500000000000004,0.67300000000000004,0.72299999999999998,null,0.72399999999999998,0.74299999999999999]
["Expense ratio ",null,0.27300000000000002,0.27100000000000002,0.27300000000000002,0.252,null,0.29099999999999998,0.26800000000000002]
["Combined ratio",null,0.96299999999999997,0.94599999999999995,0.94599999999999995,0.97599999999999998,null,1.014,1.0109999999999999]
[]
["Net new contracts (thous. policy count)"]
["Motor",null,-576,-47,57,11,null,-597]
["Household",null,-275,-64,-190,13,null,-34]
[]
["Health"]
["Earned revenues (gross) ",null,12422,3877,5132,1965,57,1218,172]
["All accident year loss ratio ",null,0.78400000000000003,0.80700000000000005,0.86899999999999999,0.54600000000000004,1.2190000000000001,0.76200000000000001,0.48599999999999999]
["Expense ratio ",null,0.16300000000000001,0.18,9.1999999999999998E-2,0.23699999999999999,0.24970000000000001,0.253,0.38500000000000001]
["Combined ratio",null,0.94699999999999995,0.98699999999999999,0.96099999999999997,0.78300000000000003,1.4690000000000001,1.016,0.871]
[]
["Protection"]
["Earned revenues (gross) ",null,21352,3880,9264,4429,3036,743]
["All accident year loss ratio ",null,0.82799999999999996,0.71099999999999997,0.90400000000000003,0.72,0.96299999999999997,0.56299999999999994]
["Expense ratio ",null,0.14099999999999999,0.24399999999999999,6.5000000000000002E-2,0.14699999999999999,0.16300000000000001,0.42099999999999999]
["Combined ratio",null,0.96899999999999997,0.95599999999999996,0.97,0.86699999999999999,1.127,0.98399999999999999]

{"sheet":"35) CoR - EUROPE (N-1)","index":36,"n_rows":32,"n_cols":9,"rows_kept":32,"cut":false,"hidden":false,"merged":[[1,0,1,8],[2,0,2,8],[3,0,3,8],[4,7,4,8],[5,7,5,8]]}
["Back to Summary"]
["COMBINED RATIO ANALYSIS & NET NEW CONTRACTS"]
["EUROPE"]
["Period ended December 31, 2016 (Restated)"]
[null,null,null,null,null,null,null,"AXA Consolidated   "]
["(Euro million) ",null,null,null,null,null,null,"Financial Statements  "]
[]
[null,null,"TOTAL","Switzerland","Germany","Belgium","United Kingdom & Ireland","Spain","Italy"]
[]
["Property & Casualty"]
["Earned revenues (gross) ",null,15698,3105,3874,2115,3417,1583,1603]
["Current accident year loss ratio",null,0.68600000000000005,0.66100000000000003,0.68500000000000005,0.67900000000000005,0.70299999999999996,0.70199999999999996,0.69799999999999995]
["o/w Nat Cat impact",null,5.0000000000000001E-3,0,1.7000000000000001E-2,1E-3,0,0,6.0000000000000001E-3]
["All accident year loss ratio ",null,0.67400000000000004,0.61699999999999999,0.70299999999999996,0.64,0.69699999999999995,0.71399999999999997,0.67200000000000004]
["Expense ratio ",null,0.27700000000000002,0.246,0.27500000000000002,0.31,0.28399999999999997,0.27500000000000002,0.28599999999999998]
["Combined ratio",null,0.95099999999999996,0.86199999999999999,0.97799999999999998,0.95,0.98099999999999998,0.98899999999999999,0.95799999999999996]
[]
["Net new contracts (thous. policy count)"]
["Motor",null,60,8,-15,20,-62,19,89]
["Household",null,104,6,-13,-8,125,-29,23]
[]
["Health"]
["Earned revenues (gross) ",null,4969,null,2876,70,1798,166,59]
["All accident year loss ratio ",null,0.86599999999999999,null,0.98199999999999998,0.93500000000000005,0.69499999999999995,0.75800000000000001,0.66700000000000004]
["Expense ratio ",null,9.7000000000000003E-2,null,-1.7999999999999999E-2,0.151,0.26200000000000001,0.17499999999999999,0.33]
["Combined ratio",null,0.96299999999999997,null,0.96499999999999997,1.0860000000000001,0.95699999999999996,0.93300000000000005,0.997]
[]
["Protection"]
["Earned revenues (gross) ",null,9782,6931,1566,807,null,331,146]
["All accident year loss ratio ",null,0.90900000000000003,0.92700000000000005,0.93400000000000005,0.84,null,0.78,0.45900000000000002]
["Expense ratio ",null,7.3999999999999996E-2,5.5E-2,6.2E-2,0.16600000000000001,null,0.16900000000000001,0.34699999999999998]
["Combined ratio",null,0.98299999999999998,0.98199999999999998,0.996,1.006,null,0.94899999999999995,0.80600000000000005]

{"sheet":"36) CoR -  EUROPE (N)","index":37,"n_rows":32,"n_cols":9,"rows_kept":32,"cut":false,"hidden":false,"merged":[[1,0,1,8],[2,0,2,8],[3,0,3,8],[4,7,4,8],[5,7,5,8]]}
["Back to Summary"]
["COMBINED RATIO ANALYSIS & NET NEW CONTRACTS"]
["EUROPE"]
["Period ended December 31, 2017"]
[null,null,null,null,null,null,null,"AXA Consolidated   "]
["(Euro million) ",null,null,null,null,null,null,"Financial Statements  "]
[]
[null,null,"TOTAL","Switzerland","Germany","Belgium","United Kingdom & Ireland","Spain","Italy"]
[]
["Property & Casualty"]
["Earned revenues (gross) ",null,15662,3080,3912,2062,3363,1604,1642]
["Current accident year loss ratio",null,0.68799999999999994,0.69099999999999995,0.69799999999999995,0.64,0.69899999999999995,0.69799999999999995,0.69099999999999995]
["o/w Nat Cat impact",null,5.0000000000000001E-3,1.7000000000000001E-2,1E-3,1E-3,1E-3,3.0000000000000001E-3,8.9999999999999993E-3]
["All accident year loss ratio ",null,0.67300000000000004,0.61599999999999999,0.69099999999999995,0.60599999999999998,0.72,0.70399999999999996,0.69199999999999995]
["Expense ratio ",null,0.27300000000000002,0.24299999999999999,0.26900000000000002,0.33,0.27100000000000002,0.27,0.27400000000000002]
["Combined ratio",null,0.94599999999999995,0.85799999999999998,0.96,0.93600000000000005,0.99099999999999999,0.97499999999999998,0.96499999999999997]
[]
["Net new contracts (thous. policy count)"]
["Motor",null,57,7,-15,-15,-113,60,132]
["Household",null,-190,2,8,-18,-213,6,25]
[]
["Health"]
["Earned revenues (gross) ",null,5132,0,3059,83,1741,183,65]
["All accident year loss ratio ",null,0.86899999999999999,0.65100000000000002,0.98199999999999998,0.95599999999999996,0.68899999999999995,0.74,0.64700000000000002]
["Expense ratio ",null,9.1999999999999998E-2,"n/a",-1.9E-2,0.14599999999999999,0.26,0.188,0.30399999999999999]
["Combined ratio",null,0.96099999999999997,"n/a",0.96299999999999997,1.1020000000000001,0.94899999999999995,0.92800000000000005,0.95099999999999996]
[]
["Protection"]
["Earned revenues (gross) ",null,9264,6630,1511,819,null,154,151]
["All accident year loss ratio ",null,0.90400000000000003,0.92500000000000004,0.93100000000000005,0.83199999999999996,null,0.54400000000000004,0.47399999999999998]
["Expense ratio ",null,6.5000000000000002E-2,4.7E-2,0.04,0.15,null,0.38600000000000001,0.35399999999999998]
["Combined ratio",null,0.97,0.97199999999999998,0.97099999999999997,0.98199999999999998,null,0.93,0.82899999999999996]

{"sheet":"37) CoR -  ASIA (N-1) ","index":38,"n_rows":32,"n_cols":7,"rows_kept":32,"cut":false,"hidden":false,"merged":[[1,0,1,6],[2,0,2,6],[3,0,3,6],[4,5,4,6],[5,5,5,6]]}
["Back to Summary"]
["COMBINED RATIO ANALYSIS & NET NEW CONTRACTS"]
["ASIA"]
["Period ended December 31, 2016 (Restated)"]
[null,null,null,null,null,"AXA Consolidated   "]
["(Euro million) ",null,null,null,null,"Financial Statements  "]
[]
[null,null,"TOTAL","Japan","Hong Kong","Asia High Potentials","Asia - Direct"]
[]
["Property & Casualty"]
["Earned revenues (gross) ",null,1306,null,236,73,997]
["Current accident year loss ratio",null,0.73,null,0.57599999999999996,0.68300000000000005,0.77]
["o/w Nat Cat impact",null,3.0000000000000001E-3,null,5.0000000000000001E-3,1E-3,3.0000000000000001E-3]
["All accident year loss ratio ",null,0.73099999999999998,null,0.55300000000000005,0.66600000000000004,0.77800000000000002]
["Expense ratio ",null,0.246,null,0.39,0.39200000000000002,0.20200000000000001]
["Combined ratio",null,0.97699999999999998,null,0.94199999999999995,1.0589999999999999,0.97899999999999998]
[]
["Net new contracts (thous. policy count)"]
["Motor",null,-98,null,-4,-1,-94]
["Household",null,26,null,29,-3,0]
[]
["Health"]
["Earned revenues (gross) ",null,2036,1447,546,39,4]
["All accident year loss ratio ",null,0.56100000000000005,0.47699999999999998,0.76600000000000001,0.81299999999999994,0.66500000000000004]
["Expense ratio ",null,0.22900000000000001,0.24,0.184,0.47399999999999998,0.29799999999999999]
["Combined ratio",null,0.79100000000000004,0.71699999999999997,0.95,1.2869999999999999,0.96199999999999997]
[]
["Protection"]
["Earned revenues (gross) ",null,4317,2418,1835,64]
["All accident year loss ratio ",null,0.68899999999999995,0.70799999999999996,0.66800000000000004,0.53]
["Expense ratio ",null,0.17100000000000001,0.17899999999999999,0.14899999999999999,0.44]
["Combined ratio",null,0.85899999999999999,0.88800000000000001,0.81799999999999995,0.97]

{"sheet":"38) CoR -  ASIA (N)","index":39,"n_rows":32,"n_cols":7,"rows_kept":32,"cut":false,"hidden":false,"merged":[[1,0,1,6],[2,0,2,6],[3,0,3,6],[4,5,4,6],[5,5,5,6]]}
["Back to Summary"]
["COMBINED RATIO ANALYSIS & NET NEW CONTRACTS"]
["ASIA"]
["Period ended December 31, 2017"]
[null,null,null,null,null,"AXA Consolidated   "]
["(Euro million) ",null,null,null,null,"Financial Statements  "]
[]
[null,null,"TOTAL","Japan","Hong Kong","Asia High Potentials","Asia - Direct"]
[]
["Property & Casualty"]
["Earned revenues (gross) ",null,1310,null,249,75,985]
["Current accident year loss ratio",null,0.72699999999999998,null,0.58899999999999997,0.754,0.76]
["o/w Nat Cat impact",null,6.0000000000000001E-3,null,1.4999999999999999E-2,1.4999999999999999E-2,3.0000000000000001E-3]
["All accident year loss ratio ",null,0.72299999999999998,null,0.57399999999999995,0.75700000000000001,0.75900000000000001]
["Expense ratio ",null,0.252,null,0.38800000000000001,0.39500000000000002,0.20699999999999999]
["Combined ratio",null,0.97599999999999998,null,0.96199999999999997,1.1519999999999999,0.96599999999999997]
[]
["Net new contracts (thous. policy count)"]
["Motor",null,11,null,1,17,-7]
["Household",null,13,null,12,1,0]
[]
["Health"]
["Earned revenues (gross) ",null,1965,1395,525,41,4]
["All accident year loss ratio ",null,0.54600000000000004,0.46700000000000003,0.75,0.60899999999999999,0.48]
["Expense ratio ",null,0.23699999999999999,0.24399999999999999,0.20200000000000001,0.41599999999999998,0.432]
["Combined ratio",null,0.78300000000000003,0.71099999999999997,0.95199999999999996,1.0249999999999999,0.91200000000000003]
[]
["Protection"]
["Earned revenues (gross) ",null,4429,2366,1997,66]
["All accident year loss ratio ",null,0.72,0.72199999999999998,0.72399999999999998,0.51]
["Expense ratio ",null,0.14699999999999999,0.159,0.125,0.437]
["Combined ratio",null,0.86699999999999999,0.88100000000000001,0.84899999999999998,0.94799999999999995]

{"sheet":"39) CoR - TRANSVERSAL (N-1) ","index":40,"n_rows":33,"n_cols":6,"rows_kept":33,"cut":false,"hidden":false,"merged":[[32,0,32,1],[1,0,1,5],[2,0,2,5],[3,0,3,5],[4,4,4,5],[5,4,5,5]]}
["Back to Summary"]
["COMBINED RATIO ANALYSIS & NET NEW CONTRACTS"]
["TRANSVERSAL & CENTRAL HOLDINGS"]
["Period ended December 31, 2016 (Restated)"]
[null,null,null,null,"AXA Consolidated   "]
["(Euro million) ",null,null,null,"Financial Statements  "]
[]
[null,null,"TOTAL","AXA Corporate Solutions Assurance","AXA Assistance","Other (a)"]
[]
["Property & Casualty"]
["Earned revenues (gross) ",null,3845,2307,1272,267]
["Current accident year loss ratio",null,0.748,0.85699999999999998,0.61599999999999999,0.44500000000000001]
["o/w Nat Cat impact",null,0,0,0,0]
["All accident year loss ratio ",null,0.72799999999999998,0.83399999999999996,0.621,0.33]
["Expense ratio ",null,0.25800000000000001,0.17799999999999999,0.37,0.42299999999999999]
["Combined ratio",null,0.98699999999999999,1.012,0.99,0.753]
[]
["Net new contracts (thous. policy count)"]
["Motor"]
["Household"]
[]
["Health"]
["Earned revenues (gross) ",null,166,null,166]
["All accident year loss ratio ",null,0.50900000000000001,null,0.50900000000000001]
["Expense ratio ",null,0.39200000000000002,null,0.39200000000000002]
["Combined ratio",null,0.9,null,0.9]
[]
["Protection"]
["Earned revenues (gross) "]
["All accident year loss ratio "]
["Expense ratio "]
["Combined ratio"]
["(a) Other includes AXA Art, AXA Gloabl Re and AXA Liabilities Managers."]

{"sheet":"40) CoR - TRANSVERSAL (N) ","index":41,"n_rows":33,"n_cols":6,"rows_kept":33,"cut":false,"hidden":false,"merged":[[32,0,32,1],[1,0,1,5],[2,0,2,5],[3,0,3,5],[4,4,4,5],[5,4,5,5]]}
["Back to Summary"]
["COMBINED RATIO ANALYSIS & NET NEW CONTRACTS"]
["TRANSVERSAL & CENTRAL HOLDINGS"]
["Period ended December 31, 2017"]
[null,null,null,null,"AXA Consolidated   "]
["(Euro million) ",null,null,null,"Financial Statements  "]
[]
[null,null,"TOTAL","AXA Corporate Solutions Assurance","AXA Assistance","Other (a)"]
[]
["Property & Casualty"]
["Earned revenues (gross) ",null,3883,2339,1271,272]
["Current accident year loss ratio",null,0.75800000000000001,0.88400000000000001,0.60399999999999998,0.39700000000000002]
["o/w Nat Cat impact",null,1.7000000000000001E-2,1.7999999999999999E-2,0,0.09]
["All accident year loss ratio ",null,0.74299999999999999,0.86199999999999999,0.59899999999999998,0.38900000000000001]
["Expense ratio ",null,0.26800000000000002,0.18,0.38800000000000001,0.46100000000000002]
["Combined ratio",null,1.0109999999999999,1.042,0.98699999999999999,0.85]
[]
["Net new contracts (thous. policy count)"]
["Motor"]
["Household"]
[]
["Health"]
["Earned revenues (gross) ",null,172,null,172]
["All accident year loss ratio ",null,0.48599999999999999,null,0.48599999999999999]
["Expense ratio ",null,0.38500000000000001,null,0.38500000000000001]
["Combined ratio",null,0.871,null,0.871]
[]
["Protection"]
["Earned revenues (gross) "]
["All accident year loss ratio "]
["Expense ratio "]
["Combined ratio"]
["(a) Other includes AXA Art, AXA Gloabl Re and AXA Liabilities Managers."]

{"sheet":"41) Number of shares","index":42,"n_rows":21,"n_cols":7,"rows_kept":21,"cut":false,"hidden":false,"merged":[[1,0,1,6],[5,0,6,0],[5,2,5,3],[5,5,5,6],[20,0,20,6]]}
["Back to Summary"]
["NUMBER OF SHARES "]
[null,null,null,null,null,null,"AXA Consolidated "]
["(million shares) ",null,null,null,null,null,"Financial Statements "]
[]
[null,null,"Period ended December 31, 2016",null,null,"Period ended December 31, 2017"]
[null,null,"Outstanding shares excluding treasury shares (a)","Weighted average number",null,"Outstanding shares excluding treasury shares (a)","Weighted average number"]
["BASIC"]
["As of January 1st",null,2424.5,2424.5,null,2419.1999999999998,2419.1999999999998]
["Increase of capital dedicated to employees",null,25.8,3,null,19.600000000000001,1.6]
["Exercice of stock-options",null,4.0999999999999996,1.1000000000000001,null,8,3.4]
["Other movement of treasury shares",null,-3.9,-4.2,null,-35.9,-17.600000000000001]
["Capital increase / (decrease)",null,-31.3,-8.6999999999999993,null,-27.5,-11.7]
["As at end of period",null,2419.1999999999998,null,null,2383.4]
["During the period",null,null,2415.6,null,null,2394.9]
[]
["FULLY DILUTED"]
["Stock options",null,null,4.7,null,null,5.3]
["Performance shares",null,null,2.9,null,null,3.7]
["During the period",null,null,2423.1999999999998,null,null,2403.9]
["(a) Under IFRS, Treasury shares are not considered as outstanding shares. Treasury shares amounted to 42 million shares as at December 31, 2017 and 6 million shares as at December 31, 2016. "]

{"sheet":"42) Earnings per share","index":43,"n_rows":38,"n_cols":4,"rows_kept":38,"cut":false,"hidden":false,"merged":[[1,0,1,3]]}
["Back to Summary"]
["EARNINGS PER SHARE"]
[null,null,null,"AXA Consolidated"]
["(Euro million)",null,null,"Financial Statements"]
[]
[null,null,"Period ended December 31, 2016","Period ended December 31, 2017"]
[]
["EARNINGS"]
["Net income",null,5829,6209]
["Adjusted earnings",null,6103,6457]
["Underlying earnings",null,5688,6002]
[]
["IMPACT OF UNDATED SUBORDINATED DEBT ON:"]
["Net income",null,-267,-229]
["Adjusted earnings",null,-267,-229]
["Underlying earnings",null,-267,-229]
[]
["BASIC"]
["Weighted average number of outstanding shares during the period (million shares)",null,2416,2395]
["Net income",null,5562,5980]
["EPS (euro per share)",null,2.2999999999999998,2.5]
["Adjusted earnings",null,5836,6228]
["Adjusted EPS (euro per share)",null,2.42,2.6]
["Underlying earnings",null,5421,5773]
["Underlying EPS (euro per share)",null,2.2400000000000002,2.41]
[]
["DILUTION IMPACTS"]
["On earnings",null,0,0]
["On weighted average number of shares (million shares)",null,8,9]
[]
["FULLY DILUTED"]
["Weighted average number of outstanding shares during the period (million shares)",null,2423,2404]
["Net income",null,5562,5980]
["EPS (euro per share)",null,2.2999999999999998,2.4900000000000002]
["Adjusted earnings",null,5836,6228]
["Adjusted EPS (euro per share)",null,2.41,2.59]
["Underlying earnings",null,5421,5773]
["Underlying EPS (euro per share)",null,2.2400000000000002,2.4]

{"sheet":"43) BS – assets","index":44,"n_rows":28,"n_cols":5,"rows_kept":28,"cut":false,"hidden":false,"merged":[[27,0,27,4],[1,0,1,4],[2,0,2,4],[24,0,24,4],[25,0,25,4],[26,0,26,4]]}
["Back to Summary"]
["BALANCE SHEET"]
["ASSETS "]
[null,null,null,null,"AXA Consolidated"]
["(Euro million) ",null,null,null,"Financial Statements"]
[]
[null,null,"Period ended December 31, 2016",null,"Period ended December 31, 2017"]
[]
["Goodwill (a)",null,16684,null,15391]
["Value of purchased Life business in force ",null,2209,null,1891]
["Deferred acquisition costs and equivalent ",null,24132,null,22881]
["Other intangible assets ",null,3266,null,3170]
["Total intangible assets (b)",null,46292,null,43333]
["General account investments - Group share ",null,538587,null,525289]
["Controlled investments funds - Minority interests assets (c)",null,13523,null,11066]
["Assets backing contracts where the financial risk is borne by policyholders ",null,175292,null,175003]
["Investments from insurance activities ",null,727402,null,711358]
["Investments from non-insurance activities ",null,35459,null,37335]
["Investment in associates (equity method) ",null,2245,null,2381]
["Reinsurers'share in insurance and investment contracts liabilities ",null,14988,null,13081]
["Assets held for sale or relating to discontinued operations (d)",null,1100,null,5019]
["Other assets and receivables ",null,38982,null,33723]
["Cash and cash equivalents ",null,26314,null,23961]
["TOTAL ASSETS ",null,892783,null,870192]
["(a) Under IFRS, Goodwill is booked in the currency of the acquired company, and therefore is impacted by currency fluctuations."]
["(b) Gross of URF, URR, Minority Interests, PB & Tax."]
["(c) Reflects minority interest share in assets held in consolidated investment funds fully consolidated, including €3,728 million relating to debt instruments, €2,981 million on equity instruments and €4,357 million on other assets as of December 31, 2017, and €6,011 million relating to debt instruments, €3,037 million on equity instruments and €4,475 million on other assets as of December 31, 2016."]
["(d)  As of December 31, 2017, amounts include the assets of  AXA Wealth Management (HK) Limited (“AWM”) and Germany pension business Pro bAV Pensionskasse AG for which the disposal process was not finalized at year-end. As of December 31, 2016, amounts include the assets of discontinued AXA Life Europe UK  operations for which the disposal process was not finalized at year-end. "]

{"sheet":"44) BS – liabilities","index":45,"n_rows":37,"n_cols":5,"rows_kept":37,"cut":false,"hidden":false,"merged":[[36,0,36,4],[1,0,1,4],[2,0,2,4],[3,0,4,0],[3,1,4,1],[3,2,4,2],[3,3,4,3]]}
["Back to Summary"]
["BALANCE SHEET"]
["LIABILITIES, MINORITY INTERESTS AND SHAREHOLDERS' EQUITY "]
["(Euro million) ",null,null,null,"AXA Consolidated"]
[null,null,null,null,"Financial Statements"]
[]
[null,null,"Period ended December 31, 2016",null,"Period ended December 31, 2017"]
[]
["Share capital and capital in excess of nominal value",null,25885,null,25033]
["Translation and other reserves",null,38883,null,38370]
["Net income for the period",null,5829,null,6209]
["Shareholders' equity",null,70597,null,69611]
["Minority interests",null,5283,null,5656]
["Total Minority interests and Shareholders' equity",null,75880,null,75267]
["Subordinated debt",null,7818,null,7086]
["Financing debt instrument issued",null,1109,null,1013]
["Financing debt owed to credit institutions",null,0,null,0]
["Total financing debt",null,8927,null,8099]
["Liabilities arising from insurance contracts",null,414569,null,401129]
["Liabilities arising from insurance contracts where the financial risk is borne by policyholders",null,160222,null,159702]
["Total liabilities arising from insurance contracts",null,574791,null,560831]
["Liabilities arising from investment contracts with discretionary participating feature",null,32466,null,33199]
["Liabilities arising from investment contracts with no discretionary participating feature",null,2382,null,2900]
["Liabilities arising from investment contracts with discretionary participating feature and financial risk is borne by policyholders",null,3593,null,3637]
["Liabilities arising from investment contracts with no discretionary participating feature and financial risk is borne by policyholders",null,11917,null,12260]
["Total liabilities arising from investment contracts",null,50358,null,51995]
["Unearned revenues and unearned fees revenues",null,2565,null,2598]
["Liabilities arising from policyholders' participation",null,49488,null,44409]
["Derivatives relating to insurance and investment contracts",null,-1903,null,-2895]
["Total liabilities arising from insurance and investment contracts",null,675299,null,656938]
["Liabilities arising from banking activities ",null,31743,null,32898]
["Provisions for risk and charges",null,13735,null,11898]
["Minority interests of controlled investment funds and puttable instruments held by Minority interest holders",null,11503,null,8756]
["Other payables and other liabilities",null,74785,null,71917]
["Liabilities held for sale or relating to discontinued operations (a)",null,910,null,4419]
["TOTAL LIABILITIES, MINORITY INTERESTS AND SHAREHOLDERS' EQUITY",null,892783,null,870192]
["(a)  As of December 31, 2017, amounts include the  liabilities of  AXA Wealth Management (HK) Limited (“AWM”) and Germany pension business Pro bAV Pensionskasse AG for which the disposal process was not finalized at year-end. As of December 31, 2016, amounts include the liabilities of discontinued AXA Life Europe UK operations for which the disposal process was not finalized at year-end.         "]

{"sheet":"45) Shareholders equity","index":46,"n_rows":37,"n_cols":5,"rows_kept":37,"cut":false,"hidden":false,"merged":[[1,0,1,4],[36,0,36,4]]}
["Back to Summary"]
["CONSOLIDATED SHAREHOLDERS' EQUITY "]
[null,null,null,null,"AXA Consolidated "]
["(Euro million) ",null,null,null,"Financial Statements "]
[]
["Change in consolidated shareholders' equity",null,null,null,"Euro million"]
[]
["Shareholders' equity as of period ended N-1",null,null,null,70597]
["Share Capital",null,null,null,0]
["Capital in excess of nominal value",null,null,null,-116]
["Equity - share based compensation",null,null,null,37]
["Treasury shares sold (bought) in open market",null,null,null,-763]
["Change in equity component of compound financial instruments",null,null,null,-95]
["Undated subordinated debt (including interests charges)",null,null,null,-560]
["Fair value recorded in shareholders' equity",null,null,null,1349]
["Fair value recorded in shareholders' equity (Cash Flow Hedge)",null,null,null,75]
["Impact of currency fluctuations",null,null,null,-4588]
["Payment of N-1 dividend",null,null,null,-2808]
["Other",null,null,null,-108]
["Net income for the period",null,null,null,6209]
["Reserves relating to own credit risk on financial liabilities",null,null,null,-23]
["Actuarial gains and losses on pension benefits",null,null,null,405]
["Shareholders' equity as of the end of the period",null,null,null,69611]
[]
["Consolidated shareholders' equity at the end of the period",null,"Period ended December 31, 2016",null,"Period ended December 31, 2017"]
[]
["Share Capital and capital in excess of nominal value",null,26537,null,26457]
["Treasury shares",null,-297,null,-1060]
["Other reserves",null,23041,null,23656]
["- of which equity component of compound financial instruments",null,95,null,"-"]
["- of which undated subordinated debt",null,8106,null,7391]
["- of which fair value recorded in shareholders' equity (a)",null,"14,841 ",null,16265]
["Translation reserve",null,61,null,-4142]
["Retained earnings brought forward",null,15425,null,18491]
["Net income for the period",null,5829,null,6209]
["Total shareholders' equity at the end of the period",null,70597,null,69611]
["(a) Includes impact of changes in fair value of derivatives for €+272 million and €+197 million as of December 31, 2017 and December 31, 2016 respectively."]

{"sheet":"46) ROE","index":47,"n_rows":22,"n_cols":5,"rows_kept":22,"cut":false,"hidden":false,"merged":[[2,0,2,3],[20,0,20,4],[21,0,21,4]]}
["Back to Summary"]
[]
["                                                RETURN ON EQUITY"]
[]
[null,null,null,null,"AXA Consolidated"]
["(Euro million)",null,null,null,"Financial Statements "]
[]
[null,null,"Period ended December 31, 2016","Period ended December 31, 2017","Change in % points "]
[]
["ROE",null,8.7999999999999995E-2,9.2999999999999999E-2,"0.5 pts"]
["Net income",null,5829,6209]
["Average adjusted shareholders' equity",null,66120,66433]
[]
["Adjusted ROE",null,0.13500000000000001,0.14499999999999999,"1.0 pts"]
["Adjusted earnings (a)",null,5836,6228]
["Average adjusted shareholders' equity (b)",null,43352,43067]
[]
["Underlying ROE",null,0.125,0.13400000000000001,"0.9 pts"]
["Underlying earnings (a)",null,5421,5773]
["Average adjusted shareholders' equity (b)",null,43352,43067]
["(a) Including adjustment to reflect financial charges related to undated subordinated debt (recorded through shareholders' equity)."]
["(b) Excluding unrealized capital gains & losses of invested assets and derivatives (recorded through shareholders' equity), and nominal value of undated subordinated debt (recorded through shareholders' equity)."]

{"sheet":"47) Financial structure","index":48,"n_rows":32,"n_cols":7,"rows_kept":32,"cut":false,"hidden":false,"merged":[[31,0,31,6],[1,0,1,6],[5,0,6,0],[5,2,6,2],[5,4,6,4],[5,6,6,6],[30,0,30,6]]}
["Back to Summary"]
["CONSOLIDATED FINANCIAL STRUCTURE "]
[null,null,null,null,null,null,"AXA Consolidated "]
["(Euro billion) ",null,null,null,null,null,"Financial Statements "]
[]
[null,null,"Period ended December 31, 2016",null,"Period ended December 31, 2017",null,"Financial interest treatment"]
[]
[]
["Financing debt instrument issued",null,1.1000000000000001,null,1]
["Financing debt owed to credit institutions",null,0,null,0]
["Financing debt (A)",null,1.1000000000000001,null,1]
["Dated subordinated debt (B)",null,7.8,null,7.1]
["Reversal of marked-to-market of interest rates derivatives (C)",null,1.3,null,0.7]
["Total gross debt (D) = (A) + (B) + (C) ",null,10.199999999999999,null,8.8000000000000007,null,"P&L"]
[]
["Undated subordinated notes (\"TSDI\") (E)",null,3,null,2.8,null,"Equity (b)"]
[]
["Undated deeply subordinated notes (\"TSS\") (F)",null,5.0999999999999996,null,4.5999999999999996,null,"Equity (b)"]
["Undated subordinated notes (\"TSDI\") and Undated deeply subordinated notes (\"TSS\") (G) = (E) +(F)",null,8.1,null,7.4,null,"Equity (b)"]
[]
["Total gross debt including TSDI &TSS (H) = (D)+(G)",null,18.3,null,16.2]
[]
["Total shareholders' equity and minority interests (including TSDI &TSS (G)) (I)",null,73.7,null,72.7]
["o/w Minority interests (a)",null,5.3,null,5.7]
["o/w Reserves relating to the change in FV of financial instruments AFS and of hedge accounting derivatives (J)",null,14.8,null,16.2]
[]
["Shareholders' equity + gross debt (K) = (I) -(J)+(D )",null,69.099999999999994,null,65.3]
[]
["Debt Gearing excluding Minority interests on consolidated investment funds and real estate companies (L) = (H) / (K)",null,0.26,null,0.25]
[]
["(a) The minority interests related to the real estate consolidated investment funds that are accounted for in shareholders' equity are excluded from the gearing calculation for €2,545 million as of December 31, 2017 and €2,136 million as of December 31, 2016."]
["(b) Financial interests net of tax on Undated Subordinated notes \"TSDI\" and Super Subordinated Notes \"TSS\": Euro 229 million in FY17 and Euro 267 million in FY16."]

{"sheet":"48) Int Ass - Group_x000a_    ","index":49,"n_rows":33,"n_cols":9,"rows_kept":33,"cut":false,"hidden":false,"merged":[[1,0,1,8],[2,0,2,8],[31,0,31,8],[32,0,32,8]]}
["Back to Summary"]
["INTANGIBLE ASSETS"]
["GROUP"]
[null,null,null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million)",null,null,null,null,null,null,null,"Financial Statements "]
[]
[null,null,"TOTAL","France","Europe","Asia","US","International","Transversal & Central Holdings"]
[]
["Period ended December 31, 2016 - 100% (Restated) "]
["Goodwill (a)",null,16684,195,5338,2750,7085,826,490]
["Deferred acquisition cost and equivalent (b)",null,24132,1419,6161,4526,10887,1053,86]
["Value of Business In force (VBI) acquired",null,2209,0,1322,858,11,18,0]
["Other intagible assets",null,3266,144,1609,253,225,288,748]
[]
["Period ended December 31, 2016 (Restated)- Group share, net of URR, UR, PB & tax when applicable"]
["Goodwill (a)",null,15402,195,5304,2729,5885,806,483]
["Deferred acquisition cost and equivalent (b)",null,12231,368,874,3415,7202,363,10]
["Value of Business In force (VBI) acquired",null,1780,0,989,770,7,14,0]
["Other intangible assets",null,2159,96,835,199,186,217,626]
[]
["Period ended December 31, 2017 - 100%"]
["Goodwill (a)",null,15391,195,5271,2464,6223,776,462]
["Deferred acquisition cost and equivalent",null,22881,1698,6225,4401,9426,1049,83]
["Value of Business In force (VBI) acquired",null,1891,0,1216,651,9,16,0]
["Other intangible assets",null,3170,148,1548,225,178,315,756]
[]
["Period ended December 31, 2017 - Group share, net of URR, UR, PB & tax when applicable"]
["Goodwill (a)",null,14285,195,5237,2444,5194,758,456]
["Deferred acquisition cost and equivalent",null,11582,501,925,3603,6164,383,7]
["Value of Business In force (VBI) acquired",null,1539,0,907,615,6,12,0]
["Other intangible assets",null,2144,106,794,178,149,232,686]
["(a) Under IFRS, Goodwill is booked in the currency of the acquired company and therefore is impacted by currency fluctuations."]
["(b) Restated to include the Deferred acquisition costs and equivalent of Property & Casualty activities in addition to those related to Life & Savings activities."]

{"sheet":"49) Int Ass - Europe  ","index":50,"n_rows":33,"n_cols":9,"rows_kept":33,"cut":false,"hidden":false,"merged":[[1,0,1,8],[2,0,2,8],[31,0,31,8],[32,0,32,8]]}
["Back to Summary"]
["INTANGIBLE ASSETS"]
["EUROPE"]
[null,null,null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million)",null,null,null,null,null,null,null,"Financial Statements "]
[]
[null,null,"TOTAL","Switzerland","Germany","Belgium","United Kingdom & Ireland","Spain","Italy"]
[]
["Period ended December 31, 2016 - 100% (Restated) "]
["Goodwill (a)",null,5338,398,1065,859,1102,1102,812]
["Deferred acquisition cost and equivalent (b)",null,6161,651,4153,147,399,295,515]
["Value of Business In force (VBI) acquired",null,1322,855,421,0,0,29,17]
["Other intangible assets",null,1609,348,111,93,48,48,961]
[]
["Period ended December 31, 2016 (Restated)- Group share, net of URR, UR, PB & tax when applicable"]
["Goodwill (a)",null,5304,398,1065,859,1102,1102,778]
["Deferred acquisition cost and equivalent (b)",null,874,291,430,33,0,76,44]
["Value of Business In force (VBI) acquired",null,989,676,286,0,0,22,6]
["Other intangible assets",null,835,273,58,61,44,36,362]
[]
["Period ended December 31, 2017 - 100%"]
["Goodwill (a)",null,5271,365,1065,859,1068,1102,812]
["Deferred acquisition cost and equivalent",null,6225,621,4202,141,397,328,536]
["Value of Business In force (VBI) acquired",null,1216,759,417,0,0,26,15]
["Other intangible assets",null,1548,296,99,100,43,49,961]
[]
["Period ended December 31, 2017 - Group share, net of URR, UR, PB & tax when applicable"]
["Goodwill (a)",null,5237,365,1065,859,1068,1102,778]
["Deferred acquisition cost and equivalent",null,925,289,440,35,0,96,65]
["Value of Business In force (VBI) acquired",null,907,599,283,0,0,20,5]
["Other intangible assets",null,794,232,56,69,39,37,362]
["(a) Under IFRS, Goodwill is booked in the currency of the acquired company and therefore is impacted by currency fluctuations."]
["(b) Restated to include the Deferred acquisition costs and equivalent of Property & Casualty activities in addition to those related to Life & Savings activities."]

{"sheet":"50) Int Ass - Asia    ","index":51,"n_rows":33,"n_cols":7,"rows_kept":33,"cut":false,"hidden":false,"merged":[[1,0,1,6],[2,0,2,6],[31,0,31,6],[32,0,32,6]]}
["Back to Summary"]
["INTANGIBLE ASSETS"]
["ASIA"]
[null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million)",null,null,null,null,null,"Financial Statements "]
[]
[null,null,"TOTAL","Japan","Hong Kong","Asia High Potentials","Asia - Direct"]
[]
["Period ended December 31, 2016 - 100% (Restated) "]
["Goodwill (a)",null,2750,1863,823,0,64]
["Deferred acquisition cost and equivalent (b)",null,4526,1533,2855,98,40]
["Value of Business In force (VBI) acquired",null,858,141,717,0,0]
["Other intangible assets",null,253,92,127,1,33]
[]
["Period ended December 31, 2016 (Restated)- Group share, net of URR, UR, PB & tax when applicable"]
["Goodwill (a)",null,2729,1845,820,0,64]
["Deferred acquisition cost and equivalent (b)",null,3415,652,2738,25,0]
["Value of Business In force (VBI) acquired",null,770,100,669,0,0]
["Other intangible assets",null,199,65,110,1,24]
[]
["Period ended December 31, 2017 - 100%"]
["Goodwill (a)",null,2464,1694,706,0,63]
["Deferred acquisition cost and equivalent",null,4401,1559,2711,88,42]
["Value of Business In force (VBI) acquired",null,651,125,526,0,0]
["Other intangible assets",null,225,91,107,1,26]
[]
["Period ended December 31, 2017 - Group share, net of URR, UR, PB & tax when applicable"]
["Goodwill (a)",null,2444,1678,703,0,63]
["Deferred acquisition cost and equivalent",null,3603,938,2642,23,0]
["Value of Business In force (VBI) acquired",null,615,88,526,0,0]
["Other intangible assets",null,178,64,94,1,19]
["(a) Under IFRS, Goodwill is booked in the currency of the acquired company and therefore is impacted by currency fluctuations."]
["(b) Restated to include the Deferred acquisition costs and equivalent of Property & Casualty activities in addition to those related to Life & Savings activities."]

{"sheet":"51) Int Ass - Transversal_x000a_    ","index":52,"n_rows":33,"n_cols":7,"rows_kept":33,"cut":false,"hidden":false,"merged":[[1,0,1,6],[2,0,2,6],[31,0,31,6],[32,0,32,6]]}
["Back to Summary"]
["INTANGIBLE ASSETS"]
["TRANSVERSAL & CENTRAL HOLDINGS"]
[null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million)",null,null,null,null,null,"Financial Statements "]
[]
[null,null,"TOTAL"," AXA Investment Managers","AXA Corporate Solutions Assurance","AXA Assistance","Other (b)"]
[]
["Period ended December 31, 2016 - 100% (Restated) "]
["Goodwill (a)",null,490,398,40,52,0]
["Deferred acquisition cost and equivalent",null,86,0,20,45,20]
["Value of Business In force (VBI) acquired",null,0,0,0,0,0]
["Other intangible assets",null,748,219,17,19,492]
[]
["Period ended December 31, 2016 (Restated)- Group share, net of URR, UR, PB & tax when applicable"]
["Goodwill (a)",null,483,391,40,52,0]
["Deferred acquisition cost and equivalent",null,10,0,0,0,10]
["Value of Business In force (VBI) acquired",null,0,0,0,0,0]
["Other intangible assets",null,626,170,11,8,437]
[]
["Period ended December 31, 2017 - 100%"]
["Goodwill (a)",null,462,377,35,50,0]
["Deferred acquisition cost and equivalent",null,83,0,19,48,16]
["Value of Business In force (VBI) acquired",null,0,0,0,0,0]
["Other intangible assets",null,756,227,20,17,491]
[]
["Period ended December 31, 2017 - Group share, net of URR, UR, PB & tax when applicable"]
["Goodwill (a)",null,456,372,34,50,0]
["Deferred acquisition cost and equivalent",null,7,0,0,0,7]
["Value of Business In force (VBI) acquired",null,0,0,0,0,0]
["Other intangible assets",null,686,175,8,11,491]
["(a) Under IFRS, Goodwill is booked in the currency of the acquired company and therefore is impacted by currency fluctuations."]
["(b) Others correspond to AXA Art, AXA Liabilities Managers, AXA Global Re, AXA Life Europe, AXA SA and other Central Holdings."]

{"sheet":"52) DAC – L&S N-1","index":53,"n_rows":29,"n_cols":11,"rows_kept":29,"cut":false,"hidden":false,"merged":[[28,0,28,10],[1,0,1,10],[2,0,2,10],[3,2,3,3],[3,7,3,10],[4,7,4,10],[27,0,27,10]]}
["Back to Summary"]
["DEFERRED ACQUISITION COSTS AND EQUIVALENT (GROSS OF TAXES AND PB)"]
["Period ended December 31, 2016 (Restated)"]
[null,null,null,null,null,null,null,"AXA Consolidated"]
["(Euro million)",null,null,null,null,null,null,"Financial Statements"]
[]
[null,null,"Period ended N-1 (a)","Capitalization for the period","Amortization for the period","Shadow DAC","Other changes (including currency changes)","Changes in scope","Change in Life DAC","Change in Non Life DAC","Period ended N (a)"]
[]
["Total",null,24028,2289,-1704,84,387,-998,58,47,24132]
["France",null,1317,229,-82,-67,0,-1,79,22,1419]
["Switzerland",null,645,67,-34,-38,6,"-",1,4,651]
["Germany",null,4058,288,-192,"-","-","-",96,-1,4153]
["Belgium",null,148,15,-21,7,"-","-",1,-2,147]
["United Kingdom",null,1534,"-",0,"-",-117,-996,-1113,-21,399]
["Spain",null,277,18,-9,10,"-","-",19,0,295]
["Italy",null,535,72,-95,"-","-","-",-23,3,515]
["Japan",null,1374,353,-216,-62,84,"-",159,"-",1533]
["Hong Kong",null,2447,414,-97,0,87,"-",405,3,2855]
["Asia High Potentials",null,93,-1,1,0,5,"-",5,0,98]
["Asia - Direct",null,44,"-","-","-","-","-","-",-4,40]
["United States",null,10473,706,-845,235,318,"-",414,"-",10887]
["International",null,988,123,-99,"-",5,0,29,36,1053]
["Other (b)",null,95,3,-16,"-",-2,0,-15,6,86]
[]
["Unearned revenue reserve and Unearned fees reserve (URR & URF)",null,3066,null,null,null,null,null,null,null,2565]
[]
["Deferred acquisition costs and equivalent (Net of URR & URF)",null,20962,null,null,null,null,null,null,null,21567]
["(a) Restated to include the Deferred acquisition costs and equivalent of Property & Casualty activities in addition to those related to Life & Savings activities."]
["(b) Other corresponds to AXA Art, AXA Liabilities Managers, AXA Global Re, AXA Life Europe, AXA SA and other Central Holdings."]

{"sheet":"53) DAC – L&S N","index":54,"n_rows":29,"n_cols":11,"rows_kept":29,"cut":false,"hidden":false,"merged":[[28,0,28,10],[1,0,1,10],[2,0,2,10],[3,2,3,3],[3,7,3,10],[4,7,4,10],[27,0,27,10]]}
["Back to Summary"]
["DEFERRED ACQUISITION COSTS AND EQUIVALENT (GROSS OF TAXES AND PB)"]
["Period ended December 31, 2017"]
[null,null,null,null,null,null,null,"AXA Consolidated"]
["(Euro million)",null,null,null,null,null,null,"Financial Statements"]
[]
[null,null,"Period ended N-1 (a)","Capitalization for the period","Amortization for the period","Shadow DAC","Other changes (including currency changes)","Changes in scope ","Change in Life DAC","Change in Non Life DAC","Period ended N"]
[]
["Total",null,24132,2228,-1039,-375,-1899,-203,-1287,35,22881]
["France",null,1419,217,-124,123,0,1,216,62,1698]
["Switzerland",null,651,57,-21,-11,-39,"-",-13,-17,621]
["Germany",null,4153,268,-72,"-","-",-149,48,1,4202]
["Belgium",null,147,18,-20,-3,"-","-",-5,-1,141]
["United Kingdom & Ireland",null,399,"-",0,"-",0,0,0,-4,397]
["Spain",null,295,19,-6,14,"-","-",27,6,328]
["Italy",null,515,82,-68,"-","-","-",14,7,536]
["Japan",null,1533,411,-259,23,-150,"-",26,"-",1559]
["Hong Kong",null,2855,345,-48,-2,-379,-58,-142,-2,2711]
["Asia High Potentials",null,98,1,1,0,-12,"-",-9,0,88]
["Asia - Direct",null,40,"-","-","-","-","-","-",2,42]
["United States",null,10887,678,-305,-518,-1316,"-",-1461,"-",9426]
["International",null,1053,131,-116,"-",-2,3,15,-19,1049]
["Other (b)",null,86,0,-3,0,0,0,-3,0,83]
[]
["Unearned revenue reserve and Unearned fees reserve (URR & URF)",null,2565,null,null,null,null,null,null,null,2586]
[]
["Deferred acquisition costs and equivalent (Net of URR & URF)",null,21567,null,null,null,null,null,null,null,20295]
["(a) Restated to include the Deferred acquisition costs and equivalent of Property & Casualty activities in addition to those related to Life & Savings activities."]
["(b) Other corresponds to AXA Art, AXA Liabilities Managers, AXA Global Re, AXA Life Europe, AXA SA and other Central Holdings."]

{"sheet":"54) VBI  – L&S N-1","index":55,"n_rows":24,"n_cols":8,"rows_kept":24,"cut":false,"hidden":false,"merged":[[23,0,23,7],[1,0,1,7],[2,0,2,7],[3,0,3,7],[4,2,4,3],[4,6,4,7],[5,6,5,7]]}
["Back to Summary"]
["VALUE OF BUSINESS IN FORCE"]
["LIFE AND SAVINGS (GROSS OF TAXES) "]
["Period ended December 31, 2016 (Restated)"]
[null,null,null,null,null,null,"AXA Consolidated"]
["(Euro million) ",null,null,null,null,null,"Financial Statements"]
[]
[null,null,"Period ended N-1","Amortization for the period","Shadow VBI","Other changes (including currency changes)","Changes in scope ","Period ended N"]
[]
["TOTAL",null,2364,-170,-25,41,"-",2209]
["France",null,"-","-","-","-","-","-"]
["Switzerland",null,941,-77,-21,12,"-",855]
["Germany",null,455,-35,"-","-","-",421]
["Belgium",null,0,-8,8,"-","-",0]
["United Kingdom",null,"-","-","-","-","-","-"]
["Spain",null,33,-3,"-","-","-",29]
["Italy",null,20,-3,"-","-","-",17]
["Japan",null,163,-17,-15,11,"-",141]
["Hong Kong",null,707,-12,1,20,"-",717]
["Asia High Potentials",null,"-","-","-","-","-","-"]
["United States",null,20,-10,1,0,"-",11]
["International",null,24,-4,"-",-2,"-",18]
["Other (a)",null,"-","-","-","-","-","-"]
["(a) Other includes AXA Assistance, AXA Life Europe, AXA Liabilities Managers, AXA Corporate Solutions Assurance, AXA Global Re and AXA Art."]

{"sheet":"55) VBI  – L&S N","index":56,"n_rows":24,"n_cols":8,"rows_kept":24,"cut":false,"hidden":false,"merged":[[23,0,23,7],[1,0,1,7],[2,0,2,7],[3,0,3,7],[4,2,4,3],[4,6,4,7],[5,6,5,7]]}
["Back to Summary"]
["VALUE OF BUSINESS IN FORCE"]
["LIFE AND SAVINGS (GROSS OF TAXES) "]
["Period ended December 31, 2017"]
[null,null,null,null,null,null,"AXA Consolidated"]
["(Euro million) ",null,null,null,null,null,"Financial Statements"]
[]
[null,null,"Period ended N-1","Amortization for the period","Shadow VBI","Other changes (including currency changes)","Changes in scope","Period ended N"]
[]
["TOTAL",null,2209,-43,-8,-171,-97,1890]
["France",null,"-","-","-","-","-","-"]
["Switzerland",null,855,-14,-12,-70,"-",759]
["Germany",null,421,-4,"-","-","-",417]
["Belgium",null,0,-1,1,"-","-",0]
["United Kingdom",null,"-","-","-","-","-","-"]
["Spain",null,29,-3,"-","-","-",26]
["Italy",null,17,-2,"-","-","-",15]
["Japan",null,141,-12,8,-13,"-",125]
["Hong Kong",null,717,-2,-6,-86,-97,526]
["Asia High Potentials",null,"-","-","-","-","-","-"]
["United States",null,11,-1,"-",-2,"-",8]
["International",null,18,-3,"-",0,0,16]
["Other (a)",null,"-","-",0,"-","-","-"]
["(a) Other includes AXA Assistance, AXA Life Europe, AXA Liabilities Managers, AXA Corporate Solutions Assurance, AXA Global Re and AXA Art. "]

{"sheet":"56) URGL","index":57,"n_rows":16,"n_cols":4,"rows_kept":16,"cut":false,"hidden":false,"merged":[[15,0,15,3],[1,0,1,3],[2,0,3,0],[2,1,3,1],[2,2,3,2],[14,0,14,3]]}
["Back to Summary"]
["NET UNREALIZED CAPITAL GAINS AND LOSSES "]
["(Euro million) ",null,null,"AXA Consolidated"]
[null,null,null,"Financial Statements "]
[]
[null,null,"Period ended December 31, 2016","Period ended December 31, 2017"]
[]
["TOTAL ",null,19507,20954]
["Net unrealized capital gains and losses on invested assets recorded through shareholders' equity (a)",null,15317,16173]
["of which debt instruments ",null,13152,13548]
["of which equity instruments ",null,1599,2142]
["Net unrealized capital gains and losses on invested assets not included in shareholders' equity (b)",null,3920,4421]
["Net unrealized capital gains and losses on owner occupied properties ",null,168,134]
["Net unrealized capital gains and losses on held for sale assets ",null,101,226]
["(a) Unrealized capital gains and losses gross of minority interests and including Forex impact  (€-0.2bn and €-0.7bn in FY2017 and FY2016 respectively)."]
["(b) Excluding unrealized gains and losses on banking loans."]

{"sheet":"57) Assets under Management","index":58,"n_rows":23,"n_cols":6,"rows_kept":23,"cut":false,"hidden":false,"merged":[[23,0,23,5],[1,0,1,5],[2,0,3,0],[2,1,3,1],[2,2,2,5],[3,2,3,5]]}
["Back to Summary"]
["ASSETS UNDER MANAGEMENT "]
["(Euro billion) ",null,"AXA Consolidated"]
[null,null,"Financial Statements"]
[]
[null,null,"Period ended December 31, 2016","Period ended December 31, 2017","Breakdown as of Period ended N","Change since Period N-1"]
[]
["General account assets ",null,628,613,0.43,-2.5000000000000001E-2]
["  of which managed by AB",null,111,85,null,-0.23699999999999999]
["  of which managed by AXA Investment Managers ",null,406,424,null,4.2999999999999997E-2]
["  of which managed by other AXA companies ",null,111,104,null,-6.0999999999999999E-2]
["Life Insurance Separate Accounts ",null,175,175,0.12,-2E-3]
["  of which managed by AB",null,38,31,null,-0.19800000000000001]
["  of which managed by AXA Investment Managers ",null,22,24,null,7.6999999999999999E-2]
["  of which managed by other AXA companies ",null,115,120,null,4.9000000000000002E-2]
["Third Party ",null,625,651,0.45,4.1000000000000002E-2]
["  of which managed by AB",null,337,353,null,4.8000000000000001E-2]
["  of which managed by AXA Investment Managers ",null,289,298,null,3.3000000000000002E-2]
["  of which managed by other AXA companies ",null,0,0,null,0]
["TOTAL",null,1429,1439,null,7.0000000000000001E-3]
["  of which managed by AB",null,486,468,null,-3.6999999999999998E-2]
["  of which managed by AXA Investment Managers ",null,717,746,null,0.04]
["  of which managed by other AXA companies ",null,225,224,null,-5.0000000000000001E-3]

{"sheet":"58) Reserves L&S   ","index":59,"n_rows":42,"n_cols":9,"rows_kept":42,"cut":false,"hidden":false,"merged":[[1,0,1,8],[2,6,2,8],[3,6,3,8],[4,6,4,8],[6,2,6,4],[6,6,6,8]]}
["Back to Summary"]
["LIFE & SAVINGS RESERVES  "]
[]
[null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million) ",null,null,null,null,null,"Financial Statements "]
[]
[null,null,"Period ended December 31, 2016 (Restated)",null,null,null,"Period ended December 31, 2017"]
[]
["Unit-Linked",null,"Net flows","Average reserves","Fee income / Average reserves (in bps)",null,"Net flows","Average reserves","Fee income / Average reserves (in bps)"]
[]
["Total",null,-979,162727,160,null,-664,171621,164]
["France",null,1320,31245,139,null,1422,33975,153]
["Switzerland",null,40,1921,75,null,-68,1868,68]
["Germany",null,429,5867,46,null,517,6422,46]
["Belgium",null,-153,2507,110,null,-263,2319,99]
["United Kingdom",null,"-","-","-",null,"-","-","-"]
["Spain",null,17,665,45,null,80,732,52]
["Italy",null,-1012,11101,65,null,299,10919,108]
["Japan",null,-133,7074,78,null,-19,7177,72]
["Hong Kong",null,220,3439,128,null,-22,3779,125]
["Asia High Potentials",null,19,211,341,null,11,227,314]
["United States",null,-2130,95024,196,null,-2643,100341,193]
["International",null,357,2485,176,null,167,2792,188]
["Other (a)",null,49,1188,65,null,-145,1071,63]
[]
["General Account",null,"Net flows","Average reserves","Investment income / Average reserves (in bps)",null,"Net flows","Average reserves","Investment income / Average reserves (in bps)"]
[]
["Total",null,2654,339449,77,null,1487,343112,72]
["France",null,1387,103341,106,null,838,105870,101]
["Switzerland",null,-641,57983,37,null,-433,56728,37]
["Germany",null,-985,42818,34,null,-844,42697,24]
["Belgium",null,-2166,24396,140,null,-899,22985,132]
["United Kingdom",null,"-","-","-",null,"-","-","-"]
["Spain",null,-52,5456,73,null,-648,5252,83]
["Italy",null,538,16376,88,null,71,16654,89]
["Japan",null,753,28710,-4,null,397,28261,-6]
["Hong Kong",null,1163,11615,0,null,1290,12734,0]
["Asia High Potentials",null,6,112,310,null,10,114,309]
["United States",null,2395,44598,128,null,1344,47720,114]
["International",null,253,3956,148,null,361,3993,158]
["Other (a)",null,3,87,301,null,"-",104,172]
["(a) Other corresponds to AXA Life Europe."]

{"sheet":"59) P&C reserves N-1","index":60,"n_rows":27,"n_cols":10,"rows_kept":27,"cut":false,"hidden":false,"merged":[[5,8,5,9],[1,0,1,9],[2,0,2,9],[3,0,3,9],[4,3,4,5],[4,8,4,9],[26,0,26,9],[7,0,8,0],[7,2,7,4],[7,5,7,7],[7,8,8,8],[7,9,8,9],[25,0,25,9]]}
["Back to Summary"]
["INSURANCE RESERVES "]
["PROPERTY & CASUALTY incl. HEALTH (a)"]
["Period ended December 31, 2016 (Restated)"]
[null,null,null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million) ",null,null,null,null,null,null,null,"Financial Statements "]
[]
[null,null,"Premiums reserves ",null,null,"Claims reserves ",null,null,"TOTAL NET RESERVES ","TOTAL GROSS RESERVES "]
[null,null,"Gross ","Reinsurance ceded ","Net ","Gross ","Reinsurance ceded ","Net "]
[]
["Total",null,11327,818,10509,55641,4465,51175,61684,66968]
["France",null,1968,111,1857,15066,727,14339,16196,17035]
["Switzerland",null,424,2,422,7628,28,7599,8022,8051]
["Germany",null,556,7,549,6735,361,6374,6924,7291]
["Belgium",null,515,2,513,5482,193,5289,5801,5996]
["United Kingdom & Ireland",null,2237,36,2201,4179,75,4104,6304,6416]
["Spain",null,875,19,856,1000,25,974,1830,1875]
["Italy",null,923,23,900,2097,30,2068,2968,3020]
["Hong Kong",null,138,14,124,510,21,489,613,649]
["Asia High Potentials",null,46,8,38,59,29,30,68,105]
["Asia - Direct",null,586,75,511,347,45,302,813,933]
["International",null,2256,286,1970,4054,479,3575,5545,6310]
["AXA Corporate Solutions Assurance",null,502,214,288,6398,2248,4150,4438,6900]
["AXA Assistance",null,194,8,185,216,21,195,380,409]
["Other (b)",null,108,14,94,1870,181,1689,1783,1978]
["(a) Health business as previously reported in the Property & Casualty segment."]
["(b) Other includes AXA Art, AXA Global Re and AXA Liabilities Managers."]

{"sheet":"60) P&C reserves N","index":61,"n_rows":27,"n_cols":10,"rows_kept":27,"cut":false,"hidden":false,"merged":[[5,8,5,9],[1,0,1,9],[2,0,2,9],[3,0,3,9],[4,3,4,5],[4,8,4,9],[26,0,26,9],[7,0,8,0],[7,2,7,4],[7,5,7,7],[7,8,8,8],[7,9,8,9],[25,0,25,9]]}
["Back to Summary"]
["INSURANCE RESERVES "]
["PROPERTY & CASUALTY incl. HEALTH (a)"]
["Period ended December 31, 2017"]
[null,null,null,null,null,null,null,null,"AXA Consolidated "]
["(Euro million) ",null,null,null,null,null,null,null,"Financial Statements "]
[]
[null,null,"Premiums reserves ",null,null,"Claims reserves ",null,null,"TOTAL NET RESERVES ","TOTAL GROSS RESERVES "]
[null,null,"Gross ","Reinsurance ceded ","Net ","Gross ","Reinsurance ceded ","Net "]
[]
["TOTAL",null,11299,809,10490,55165,3952,51214,61704,66464]
["France",null,2092,129,1963,15553,758,14795,16758,17645]
["Switzerland",null,391,9,382,6907,42,6865,7247,7298]
["Germany",null,556,6,550,6941,331,6610,7160,7497]
["Belgium",null,508,1,507,5447,174,5273,5781,5956]
["United Kingdom & Ireland",null,2220,27,2194,4374,89,4285,6479,6595]
["Spain",null,886,10,876,1037,28,1009,1885,1924]
["Italy",null,954,25,929,2124,37,2087,3017,3078]
["Hong Kong",null,134,13,120,482,35,447,567,616]
["Asia High Potentials",null,43,5,38,44,11,33,71,87]
["Asia - Direct",null,571,71,500,367,32,335,835,938]
["International",null,2160,279,1881,4199,694,3505,5386,6359]
["AXA Corporate Solutions Assuarnce",null,472,227,245,5861,1749,4112,4357,6333]
["AXA Assistance",null,205,6,199,218,22,195,394,423]
["Other (b)",null,105,0,106,1611,-50,1661,1767,1717]
["(a) Health business as previously reported in the Property & Casualty segment."]
["(b) Other includes AXA Art, AXA Global Re and AXA Liabilities Managers."]

{"sheet":"61) P&C reserves ratios","index":62,"n_rows":28,"n_cols":7,"rows_kept":28,"cut":false,"hidden":false,"merged":[[25,0,25,6],[26,0,26,6],[27,0,27,6],[1,0,1,6],[2,0,2,6],[6,0,7,0],[6,2,6,3],[6,5,6,6],[24,0,24,6]]}
["Back to Summary"]
["RESERVES RATIOS (a)"]
["PROPERTY & CASUALTY incl. HEALTH (b)"]
[null,null,null,null,null,null,"AXA Consolidated "]
[null,null,null,null,null,null,"Financial Statements "]
[]
[null,null,"Net technical reserves / Net earned premiums",null,null,"Net claims reserves / Net claims paid (c)"]
[null,null,"Period ended December 31, 2016 (Restated)","Period ended December 31, 2017",null,"Period ended December 31, 2016 (Restated)","Period ended December 31, 2017"]
[]
["Total",null,1.92,1.95,null,2.69,2.72]
["France",null,2.4300000000000002,2.5499999999999998,null,3.99,4.01]
["Switzerland",null,2.63,2.42,null,4.32,3.85]
["Germany",null,1.87,1.92,null,2.95,3.07]
["Belgium",null,2.74,2.78,null,4.12,4.25]
["UK/Ireland",null,1.28,1.35,null,1.33,1.48]
["Spain",null,1.07,1.08,null,0.91,0.92]
["Italy",null,1.83,1.81,null,1.99,1.97]
["Hong Kong",null,1.6,1.52,null,2.4700000000000002,2.2200000000000002]
["Asia High Potentials",null,0.96,0.99,null,0.66,0.65]
["Asia - Direct",null,1,1.01,null,0.6,0.66]
["International",null,1.3,1.28,null,1.36,1.35]
["AXA Corporate Solutions Assurance",null,3.32,3.11,null,4.16,4.09]
["AXA Assistance",null,0.33,0.47,null,0.42,0.44]
["Other (d)",null,5.18,4.62,null,8.3800000000000008,11.02]
["(a) Net of reinsurance."]
["(b) Health business as previously reported in the Property & Casualty segment."]
["(c) Includes policyholder participation."]
["(d) Other includes AXA Art, AXA Global Re and AXA Liabilities Managers."]

{"sheet":"62) IRR_Payback","index":63,"n_rows":18,"n_cols":8,"rows_kept":18,"cut":false,"hidden":false,"merged":[[16,0,16,7],[17,0,17,7],[1,0,1,7],[2,0,2,7],[3,0,3,7],[4,6,4,7],[5,6,5,7],[7,0,8,0],[7,2,7,3],[7,4,7,5],[7,6,7,7]]}
["Back to Summary"]
["NEW BUSINESS IRR AND PAYBACK PERIOD"]
["LIFE & SAVINGS"]
[]
[null,null,null,null,null,null,"AXA Consolidated"]
[null,null,null,null,null,null,"Financial Statements"]
[]
[null,null,"New business IRR (%)   (a)",null,"Payback Period (year)",null,"New Business Investments (€m)  (b)"]
[null,null,"  2016 restated",2017,"  2016 restated",2017,"  2016 restated",2017]
[]
["France",null,0.21099999999999999,0.22,4,4,-298,-326]
["Europe",null,0.217,0.2,4,5,-158,-190]
["Asia",null,0.186,0.151,4,6,-675,-731]
["United States",null,0.157,0.152,6,6,-474,-465]
["International",null,6.4000000000000001E-2,6.2E-2,14,15,-80,-112]
["TOTAL",null,0.17799999999999999,0.16300000000000001,5,6,-1699,-1824]
["(a) calculated based on Solvency II required capital for entities in Europe Economic Area."]
["(b) New Business strain + New Business required capital."]

{"sheet":"63) APE - NBV Discrete N-1","index":64,"n_rows":24,"n_cols":17,"rows_kept":24,"cut":false,"hidden":false,"merged":[[1,0,1,16],[2,0,3,0],[2,1,3,1],[2,2,3,2],[2,3,3,3],[2,4,3,4],[2,5,3,5],[2,6,3,9],[2,10,3,10],[2,11,3,11],[21,0,21,16],[22,0,22,16],[23,0,23,16],[24,0,24,16],[2,12,3,12],[2,13,3,13],[2,14,3,14],[2,15,2,16],[3,15,3,16],[5,2,5,4],[5,5,5,7],[5,8,5,10],[5,11,5,13],[5,14,5,16]]}
["Back to Summary"]
["QUARTERLY NEW BUSINESS APE, NBV AND NBV MARGIN 2016 (Restated)"]
["(Euro million) ",null,null,null,null,null,"LIFE & SAVINGS incl. HEALTH (a)",null,null,null,null,null,null,null,null,"AXA Consolidated"]
[null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Financial Statements"]
[]
[null,null,"1Q16",null,null,"2Q16",null,null,"3Q16",null,null,"4Q16",null,null,"FY16"]
[null,null,"NBV","APE","NBV Margin","NBV","APE","NBV Margin","NBV","APE","NBV Margin","NBV","APE","NBV Margin","NBV","APE","NBV Margin"]
[]
["TOTAL (b)",null,656,1722,0.38100000000000001,640,1545,0.41499999999999998,610,1495,0.40799999999999997,717,1838,0.39,2623,6600,0.39700000000000002]
["France ",null,129,411,0.313,139,445,0.313,120,391,0.308,177,577,0.30599999999999999,565,1824,0.31]
["Switzerland",null,93,153,0.60599999999999998,34,50,0.67,21,42,0.5,26,55,0.48,174,301,0.57899999999999996]
["Germany",null,51,107,0.48099999999999998,36,84,0.43099999999999999,39,88,0.441,38,103,0.36699999999999999,164,382,0.43]
["Belgium",null,6,12,0.51900000000000002,9,12,0.75600000000000001,7,11,0.60099999999999998,10,20,0.497,32,55,0.57899999999999996]
["Spain",null,17,22,0.76,23,28,0.80200000000000005,15,17,0.83799999999999997,10,18,0.56999999999999995,64,86,0.75]
["Italy",null,35,87,0.39900000000000002,29,73,0.39400000000000002,22,55,0.39500000000000002,22,85,0.25700000000000001,107,300,0.35699999999999998]
["Japan",null,113,119,0.95,127,133,0.95,132,123,1.069,119,124,0.96,490,499,0.98199999999999998]
["Hong Kong",null,73,120,0.61099999999999999,88,107,0.82099999999999995,105,132,0.79100000000000004,136,177,0.76800000000000002,402,536,0.749]
["Asia High Potentials",null,37,213,0.17299999999999999,52,144,0.36,51,136,0.374,54,133,0.40799999999999997,194,626,0.31]
["United States",null,92,412,0.223,92,409,0.22600000000000001,90,438,0.20499999999999999,104,473,0.219,378,1732,0.218]
["International",null,11,62,0.17,11,55,0.2,11,58,0.19400000000000001,21,71,0.29399999999999998,54,246,0.218]
["Other (c)",null,0,4,9.4E-2,1,4,0.17899999999999999,-1,3,-0.35099999999999998,0,2,0,0,14,0]
["(a) Only includes \"life-like\" Health business."]
["(b) Following the disposal announcements, the UK APE and NBV contributions have been removed for 2016."]
["(c) Other corresponds to AXA Life Europe and Family Protect. "]

{"sheet":"64) APE - NBV Discrete N","index":65,"n_rows":23,"n_cols":17,"rows_kept":23,"cut":false,"hidden":false,"merged":[[1,0,1,16],[2,0,3,0],[2,1,3,1],[2,2,3,2],[2,3,3,3],[2,4,3,4],[2,5,3,5],[2,6,3,9],[2,10,3,10],[2,11,3,11],[21,0,21,16],[22,0,22,16],[2,12,3,12],[2,13,3,13],[2,14,3,14],[2,15,2,16],[3,15,3,16],[5,2,5,4],[5,5,5,7],[5,8,5,10],[5,11,5,13],[5,14,5,16]]}
["Back to Summary"]
["QUARTERLY NEW BUSINESS APE, NBV AND NBV MARGIN 2017"]
["(Euro million) ",null,null,null,null,null,"LIFE & SAVINGS incl. HEALTH (a)",null,null,null,null,null,null,null,null,"AXA Consolidated"]
[null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Financial Statements"]
[]
[null,null,"1Q17",null,null,"2Q17",null,null,"3Q17",null,null,"4Q17",null,null,"FY17"]
[null,null,"NBV","APE","NBV Margin","NBV","APE","NBV Margin","NBV","APE","NBV Margin","NBV","APE","NBV Margin","NBV","APE","NBV Margin"]
[]
["TOTAL",null,735,1785,0.41199999999999998,678,1545,0.439,620,1427,0.434,755,1713,0.441,2787,6470,0.43099999999999999]
["France ",null,158,442,0.35799999999999998,146,448,0.32700000000000001,140,424,0.33100000000000002,192,534,0.36,637,1849,0.34499999999999997]
["Switzerland",null,87,135,0.64500000000000002,34,47,0.72699999999999998,24,35,0.69,27,43,0.63200000000000001,172,259,0.66400000000000003]
["Germany",null,69,104,0.66200000000000003,49,80,0.60799999999999998,49,81,0.6,44,96,0.45900000000000002,210,361,0.58199999999999996]
["Belgium",null,6,7,0.90600000000000003,12,16,0.73899999999999999,9,10,0.91,15,23,0.65300000000000002,42,56,0.754]
["Spain",null,13,18,0.72499999999999998,17,18,0.92700000000000005,12,14,0.89100000000000001,19,23,0.84099999999999997,61,73,0.84299999999999997]
["Italy",null,25,68,0.36399999999999999,24,67,0.36699999999999999,18,55,0.32900000000000001,32,94,0.33700000000000002,99,284,0.34899999999999998]
["Japan",null,127,126,1.008,123,106,1.161,120,101,1.1879999999999999,124,108,1.1499999999999999,495,441,1.121]
["Hong Kong",null,73,118,0.62,76,103,0.73899999999999999,70,104,0.67,71,130,0.54800000000000004,291,456,0.63800000000000001]
["Asia High Potentials",null,55,223,0.249,54,121,0.44800000000000001,66,136,0.49,105,134,0.78200000000000003,281,613,0.45800000000000002]
["United States",null,106,478,0.222,124,476,0.26,92,398,0.23200000000000001,99,447,0.221,421,1799,0.23400000000000001]
["International",null,15,66,0.221,18,63,0.28499999999999998,19,69,0.28000000000000003,26,81,0.32400000000000001,78,278,0.28000000000000003]
["Other (b)",null,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[" (a) Only includes \"life-like\" Health business."]
["(b) Other corresponds to AXA Life Europe."]

{"sheet":"65) NB APE, NBV, NBV MARGIN","index":66,"n_rows":24,"n_cols":16,"rows_kept":24,"cut":false,"hidden":false,"merged":[[1,0,1,15],[2,0,3,0],[2,1,3,1],[2,2,3,2],[2,3,3,3],[2,4,3,4],[2,5,3,9],[2,10,3,10],[2,11,3,11],[2,12,3,12],[22,0,22,15],[23,0,23,15],[2,13,3,13],[2,14,2,15],[3,14,3,15],[6,0,7,0],[6,2,6,6],[6,7,6,9],[6,10,6,12],[6,13,6,15]]}
["Back to Summary"]
["NEW BUSINESS APE, NBV AND NBV MARGIN  (Restated)"]
["(Euro million) ",null,null,null,null,"LIFE & SAVINGS incl. HEALTH (a)",null,null,null,null,null,null,null,null,"AXA Consolidated"]
[null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Financial Statements"]
[]
[]
[null,null,"APE by product - Period ended December 31, 2017",null,null,null,null,"TOTAL APE",null,null,"NBV",null,null,"NBV Margin"]
[null,null,"Protection","Health","G/A Savings","Unit-Linked","Mutual funds & other","FY 2016 (Restated)","FY 2017","Change on a comparable basis","FY 2016 (Restated)","FY 2017","Change on a comparable basis","FY 2016 (Restated)","FY 2017","Change on a comparable basis"]
[]
["Total",null,2057,863,1269,1631,651,6600,6470,-4.0000000000000001E-3,2623,2787,8.3000000000000004E-2,0.39700000000000002,0.43099999999999999,"3.5 pt"]
["France",null,387,518,558,387,"                     -   ",1824,1849,1.7000000000000001E-2,565,637,0.13100000000000001,0.31,0.34499999999999997,"3.5 pt"]
["Switzerland",null,245,"                     -   ",0,9,5,301,259,-0.12,174,172,8.0000000000000002E-3,0.57899999999999996,0.66400000000000003,"8.5 pt"]
["Germany",null,83,108,118,35,18,382,361,-5.5E-2,164,210,0.27900000000000003,0.43,0.58199999999999996,"15.2 pt"]
["Belgium",null,24,"                     -   ",27,5,"                     -   ",55,56,1.0999999999999999E-2,32,42,0.318,0.57899999999999996,0.754,"17.5 pt"]
["Spain",null,22,"                     -   ",12,27,12,86,73,-0.14799999999999999,64,61,-4.2000000000000003E-2,0.75,0.84299999999999997,"9.3 pt"]
["Italy",null,40,"                     -   ",110,134,"                     -   ",300,284,-5.0999999999999997E-2,107,99,-7.1999999999999995E-2,0.35699999999999998,0.34899999999999998,"(0.8 pt)"]
["Japan",null,288,107,47,"                     -   ","                     -   ",499,441,-7.4999999999999997E-2,490,495,5.6000000000000001E-2,0.98199999999999998,1.121,"13.9 pt"]
["Hong Kong",null,331,48,64,13,"                     -   ",536,456,-0.128,402,291,-0.25800000000000001,0.749,0.63800000000000001,"(11.2 pt)"]
["Asia High Potentials",null,313,64,233,3,"                     -   ",626,613,5.0000000000000001E-3,194,281,0.496,0.31,0.45800000000000002,"15.1 pt"]
["United States",null,197,3,84,920,596,1732,1799,6.2E-2,378,421,0.13900000000000001,0.218,0.23400000000000001,"1.6 pt"]
["International",null,127,15,15,99,21,246,278,0.14899999999999999,54,78,0.46,0.218,0.28000000000000003,"5.9 pt"]
["Other (b)",null,0,0,0,0,0,14,0,-1,0,0,0,0,0,"0.0pt"]
[" (a) Only includes “life-like” Health business"]
["(b) Other corresponds to AXA Life Europe."]

{"sheet":"66) GR L&S","index":67,"n_rows":43,"n_cols":14,"rows_kept":43,"cut":false,"hidden":false,"merged":[[42,0,42,4],[1,0,1,13],[2,12,2,13],[3,12,3,13],[5,0,6,0],[5,2,5,5],[5,6,5,9],[5,10,5,13],[22,0,22,8],[24,0,25,0],[24,2,24,5],[24,6,24,9],[24,10,24,13]]}
["Back to Summary"]
["GROSS REVENUES BY PRODUCT"]
[null,null,null,null,null,null,null,null,null,null,null,null,"AXA Consolidated"]
["(Euro million)",null,null,null,null,null,null,null,null,null,null,null,"Financial Statements"]
[]
["Life & Savings ",null,"Period ended December 2016 (Restated)",null,null,null,"Period ended December 2017",null,null,null,"Change on a comparable basis"]
[null,null,"Protection","G/A Savings","Unit-Linked","Mutual funds & other","Protection","G/A Savings","Unit-Linked","Mutual funds & other","Protection","G/A Savings","Unit-Linked","Mutual funds & other"]
[]
["TOTAL",null,21725,13096,14549,2671,21428,11706,15187,1585,-5.0000000000000001E-3,-8.5000000000000006E-2,0.05,-0.379]
["France",null,3904,5599,3108,1001,3880,5816,3521,-66,0,3.9E-2,0.13300000000000001,-1.0660000000000001]
["Switzerland",null,6928,76,40,0,6626,55,46,0,-2.4E-2,-0.26,0.157,0]
["Germany",null,1559,1218,763,245,1505,1114,810,267,-2.5999999999999999E-2,-8.5999999999999993E-2,9.4E-2,-5.0999999999999997E-2]
["Belgium",null,807,309,94,0,819,326,34,0,1.4E-2,5.6000000000000001E-2,-0.63900000000000001,-1]
["United Kingdom",null,0,0,25,45,0,0,2,56,0,0,-0.20499999999999999,-0.11899999999999999]
["Spain",null,334,303,148,9,157,180,220,13,-0.52400000000000002,-0.40600000000000003,0.49199999999999999,2.5000000000000001E-2]
["Italy",null,199,2672,541,0,212,1857,917,0,6.6000000000000003E-2,-0.30499999999999999,0.69599999999999995,0.76100000000000001]
["Japan",null,2418,1285,12,0,2366,794,92,0,2.3E-2,-0.25700000000000001,-0.46600000000000003,0]
["Hong Kong",null,1835,276,290,-27,1997,248,137,2,7.9000000000000001E-2,0.17399999999999999,-0.51400000000000001,-5.7000000000000002E-2]
["Asia High Potentials",null,64,0,0,0,66,0,0,0,4.4999999999999998E-2,0,0,0]
["United States",null,2926,974,9040,1347,3036,906,8956,1256,4.0000000000000001E-3,-4.9000000000000002E-2,1.2999999999999999E-2,8.5000000000000006E-2]
["International",null,752,384,350,45,766,411,446,56,0.03,7.1999999999999995E-2,0.28999999999999998,0.14299999999999999]
["Other (a)",null,0,0,138,6,0,0,7,0,0,0,-0.94899999999999995,-1]
[" (a) Other corresponds to AXA Life Europe."]
[]
["Property & Casualty",null,"Period ended December 2016 (Restated)",null,null,null,"Period ended December 2017",null,null,null,"Change on a comparable basis"]
[null,null,"Personal Motor","Personal Non-Motor","Commercial Motor","Commercial Non-Motor","Personal Motor","Personal Non-Motor","Commercial Motor","Commercial Non-Motor","Personal Motor","Personal Non-Motor","Commercial Motor","Commercial Non-Motor"]
[]
["TOTAL",null,10398,6082,3659,11466,10093,6438,3568,11544,-7.0000000000000001E-3,1.2999999999999999E-2,0,2.9000000000000001E-2]
["France",null,2013,2115,588,2635,2011,2157,577,2562,-1.2999999999999999E-2,1.7999999999999999E-2,-1.7999999999999999E-2,1.4E-2]
["Switzerland",null,1135,577,119,1280,1111,563,113,1283,-1E-3,2E-3,1.4E-2,3.4000000000000002E-2]
["Germany",null,1223,1060,215,1149,1228,1206,216,1188,4.0000000000000001E-3,1.7000000000000001E-2,2E-3,3.4000000000000002E-2]
["Belgium",null,629,476,246,682,633,477,256,678,5.0000000000000001E-3,1E-3,4.8000000000000001E-2,-4.7E-2]
["United Kingdom & Ireland",null,1265,734,597,935,1223,647,634,867,7.0000000000000001E-3,-6.3E-2,0.122,1.4999999999999999E-2]
["Spain",null,890,352,67,288,892,351,53,310,0.03,-3.0000000000000001E-3,-8.2000000000000003E-2,6.0999999999999999E-2]
["Italy",null,979,331,49,260,849,342,197,275,1.6E-2,2.9000000000000001E-2,3.1E-2,4.8000000000000001E-2]
["Hong Kong",null,39,86,10,115,42,88,8,117,0.1,4.5999999999999999E-2,-0.108,7.3999999999999996E-2]
["Asia High Potentials",null,960,100,6,32,920,103,6,29,-3.2000000000000001E-2,3.9E-2,1.4999999999999999E-2,-6.5000000000000002E-2]
["Asia - Direct",null,929,93,0,0,889,96,0,0,-3.1E-2,3.4000000000000002E-2,0,0]
["International",null,1264,252,920,1329,1185,313,796,1504,-5.8999999999999997E-2,0.14599999999999999,-8.1000000000000003E-2,9.7000000000000003E-2]
["AXA Corporate Solutions Assurance",null,0,0,202,2118,0,0,207,2115,0,0,3.2000000000000001E-2,2.1999999999999999E-2]
["AXA Assistance",null,0,0,639,642,0,0,505,611,0,0,-1.4E-2,2.1999999999999999E-2]
["Other (a)",null,0,0,0,0,0,190,0,5,0,8.2000000000000003E-2,0,0]
[" (a) Other corresponds to AXA Life Europe, AXA Art, AXA Global Re and AXA Liabilities Managers."]

{"sheet":"67) GR Health","index":68,"n_rows":23,"n_cols":5,"rows_kept":23,"cut":false,"hidden":false,"merged":[[5,0,6,0],[5,2,6,2],[5,3,6,3],[5,4,6,4],[2,3,2,4],[3,3,3,4],[1,0,1,4]]}
["Back to Summary"]
["GROSS REVENUES BY PRODUCT"]
[null,null,null,"AXA Consolidated"]
["(Euro million)",null,null,"Financial Statements"]
[]
["Health (in Euro million)",null,"FY 2016 (Restated)","FY 2017","Change in comparable basis"]
[]
[]
["TOTAL",null,11959,12403,6.2E-2]
["France",null,3404,3877,0.13900000000000001]
["Switzerland",null,0,0,0]
["Germany",null,2876,3059,6.4000000000000001E-2]
["Belgium",null,70,87,-0.17399999999999999]
["United Kingdom & Ireland",null,1824,1700,1.7999999999999999E-2]
["Spain",null,173,188,8.7999999999999995E-2]
["Italy",null,62,70,0.13200000000000001]
["Japan",null,1447,1395,8.0000000000000002E-3]
["Hong Kong",null,551,530,4.5999999999999999E-2]
["Asia High Potentials",null,39,42,8.7999999999999995E-2]
["Asia - Direct",null,4,4,-0.11799999999999999]
["United States",null,55,57,6.2E-2]
["International",null,1288,1235,0]
["AXA Assistance",null,167,158,5.5E-2]

{"sheet":"68) All Free cash flows","index":69,"n_rows":19,"n_cols":7,"rows_kept":19,"cut":false,"hidden":false,"merged":[[17,0,17,6],[18,0,18,6],[1,0,1,6],[2,0,2,6],[3,3,3,6],[4,3,4,6],[6,4,6,6],[16,0,16,6]]}
["Back to Summary"]
["OPERATING FREE CASH FLOWS"]
[]
[null,null,null,"AXA Consolidated"]
[" (Euro million) ",null,null,"Financial Statements"]
[]
[null,null,"FY 2016","FY 2017","FY 2017"]
[null,null,"Group Operating FCF","Group Operating FCF","Life & Savings incl. Health (a)","Property & Casualty incl. Health (b)","Bank & Asset Management"]
[]
["TOTAL",null,6174,6292,3035,2659,598]
["France",null,1687,1404,866,539,-1]
["Europe",null,2387,2744,1142,1596,6]
["Asia",null,477,379,319,60,0]
["United States",null,805,975,692,0,283]
["International",null,314,317,9,255,53]
["Other (c)",null,504,473,8,209,257]
["(a) Only includes \"life-like\" Health business."]
["(b) Health business as previously reported in the Property & Casualty segment."]
["(c) Other for Life & Savings incl. Health includes AXA Life Europe, for Property & Casualty incl.Health includes AXA Corporate Solutions Assurance, AXA Assistance, AXA Liabilities Managers, AXA Art and AXA Global Re, and for Bank and Asset Management includes AXA Investment Managers."]

{"sheet":"69) LnS Free cash flows","index":70,"n_rows":17,"n_cols":4,"rows_kept":17,"cut":false,"hidden":false,"merged":[[1,0,1,3],[2,0,2,3],[3,2,3,3],[4,2,4,3],[6,2,7,2],[6,3,7,3]]}
["Back to Summary"]
["OPERATING FREE CASH FLOWS"]
["LIFE & SAVINGS incl. HEALTH (a)"]
[null,null,"AXA Consolidated"]
[" (Euro million) ",null,"Financial Statements"]
[]
[null,null,"FY 2016","FY 2017"]
[]
[]
["Expected Statutory Earnings",null,2956,3034]
["o/w Expected existing business earnings",null,4227,4402]
["o/w New business strain",null,-1271,-1368]
["Expected change in Required Capital",null,-11,2]
["o/w Expected existing business change in required capital",null,416,457]
["o/w New business required capital",null,-427,-456]
["TOTAL",null,2945,3035]
["(a) Only includes \"life-like\" Health business."]

{"sheet":"70) PnC & B&AM Free cash flows","index":71,"n_rows":14,"n_cols":6,"rows_kept":14,"cut":false,"hidden":false,"merged":[[12,0,12,5],[13,0,13,5],[1,0,1,5],[2,0,2,5],[3,2,3,5],[4,2,4,5],[6,2,6,3],[6,4,6,5]]}
["Back to Summary"]
["OPERATING FREE CASH FLOWS"]
["PROPERTY & CASUALTY incl. HEALTH, BANK AND ASSET MANAGEMENT"]
[null,null,"AXA Consolidated"]
[" (Euro million) ",null,"Financial Statements"]
[]
[null,null,"FY 2016",null,"FY 2017"]
[null,null,"Property & Casualty incl. Health (a)","Bank & Asset Management","Property & Casualty incl. Health (a)","Bank & Asset Management"]
[]
["Earnings contribution (b)",null,2874,494,2755,598]
["Change in Required Capital",null,-140,0,-96,0]
["TOTAL ",null,2734,494,2659,598]
["(a) Health business as previously reported in Property & Casualty segment."]
["(b) IFRS Underlying Earnings including Realized Capital gains."]